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Abbreviations
bp base pair
bl basal lamina
Cdk5 cyclin-dependent kinase 5
CMT1A Charcot Marie Tooth disease type 1A
CNS central nervous system
Cx connexin
DM20 small isoform of the proteolipid protein
DNA desoxyribonucleic acic
EAE experimental autoimmune encephalomyelitis
encephalomyeliniEM lectron microscopy
ERK1/2 extracellular signal-regulated kinases
GSK-3 glycogen-synthetase kinase 3
GFP green fluorescent protein
HNPP hereditary neuropathy with liability to pressure palsies
HMSN hereditary motor and sensory neuropathy
IPL intraperiod line
kb kilo base pairs
kD kilo Dalton
KSP lysine-serine-proline
MAG myelin-associated glycoprotein
MDL major dense line
MBP myelin basic protein
MOG myelin oligodendrocyte protein
NCV nerve conduction velocity
NF-H neurofilament heavy chain
NF-L neurofilament light chain
NF-M neurofilament medium chain
NND nearest neighbor distance
mRNA messenger ribonucleic acid
L-MAG large myelin-associated glycoprotein isoform
PBS phosphate buffer saline
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PDGFα patelet derived growth factor alpha
PCR polymerase chain reaction
PLP proteolipid protein
PMP22 peripheral myelin protein 22
PNS peripheral nervous system
P0 myelin protein zero
RT room temperature
S-MAG short myelin-associated glycoprotein isoform
YAC yeast artificial chromosome
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Summary
An intact myelin sheath is crucial for the rapid propagation of action potentials along
myelinated axons. There are many neurodegenerative diseases associated with defect myelin
sheaths resulting in severe clinical symptoms such as multiple sclerosis and a group of hereditary
neuropathies called “Charcot Marie Tooth diseases”. For the maintenance of both, the integrity
of the axon and the myelin sheath, reciprocal signaling between the axon and glia is required.
Some molecular components involved in these interactions between glial cells and the axons
have been investigated. One of these molecules is MAG, the myelin associated glycoprotein,
inserted into the periaxonal glial membrane. MAG is expressed as a large and a small isoform (L-
MAG, S-MAG) that display a common extracellular but different intracellular domains that
cannot be discriminated by antibody staining. In the first part of the thesis, the question how L-
and S-MAG are differentially expressed in the CNS and PNS was addressed. For this study a
transgenic mouse that expresses the small MAG isoform tagged with green fluorescent protein
(GFP) was previously generated (Erb. et al). In the CNS, L- and S-MAG were differentially
expressed in certain brain regions such as the corpus callosum and the perforant pathway. In
some myelinated fibers L-MAG was predominantly expressed, in others only S-MAG. In the PNS,
S-MAG was the predominant isoform; L-MAG was only weakly detectable very early during
development. In the PNS, S-MAG-GFP was localized in the expected compartments such as
periaxonal membranes, paranodes and Schmidt-Lanterman incisures. In addition, S-MAG was
expressed in ring- or disc-like compartments surrounding axons suggesting that there are
incisure-like structures distinct from classical Schmidt-Lanterman incisures. The S-MAG-GFP
mouse will be a valuable animal model to study the dynamic processes during the formation of
Schmidt-Lanterman incisures or paranodal structures in vitro.
“Charcot Marie Tooth” diseases are classified into demyelinating and axonal forms and
subdivided into different subtypes according to their genetic backgrounds. CMT1A has been
classified as primary demyelinating disease and is caused by a duplication of the DNA region
encoding the compact myelin protein PMP22 (peripheral myelin protein 22), which results in an
overexpression of PMP22. The effects of PMP22 overexpression on the Schwann cells have been
well studied. Overexpression of PMP22 impairs Schwann cell differentiation and myelination,
and results in accumulations of PMP22. In the second part of this thesis, the question how
abnormal Schwann cells influence the development of axons, especially the axonal cytoskeleton,
in an animal model for CMT1A disease was addressed. The analysis was focused on the
establishment of the neurofilament system during development. In particular, the neurofilament
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subunit composition (content of heavy, medium and light chain) and phosphorylation were
investigated. In CMT1A mice, there were early changes in the subunit composition and
phosphorylation. The axonal pathology in CMT1A mice is marked by a strong increase of the
non-phosphorylated neurofilament heavy chains (NF-H) relative to NF-M and NF-L. As
unbalanced neurofilament subunits stoichiometries have been associated with reduced axonal
calibers, they may account for the predominance of small caliber myelinated axons observed in
CMT1A mice. The precise molecular mechanisms by which Schwann cells influence the
neurofilament system are not known. However, it was hypothesized that MAG regulates
neurofilament phosphorylation interacting with its axonal receptor that induces the activity of
Cdk5 or ERK1/2 kinases in the axons. Therefore, the expression of MAG was investigated
CMT1A mice to see whether it may correlate with the neurofilament phosphorylation pattern.
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General introduction
The interaction of myelin and axons in health and disease is the general subject of the thesis
presented here. The purpose of the following section is to give an introduction in the field of
myelin biology and particular aspects of axon biology. First, the functional role of myelin, its
architecture and biochemical composition will be described. Then a series of peripheral
neuropathies called “Charcot Marie Tooth” diseases will be shortly presented. Finally, the
structure of neurofilaments, the major cytoskeletal elements in neurons, will be described as
neurofilaments are generally affected by myelin disorders.
1 The myelin sheath and propagation of action potentials
Myelination of axons is an exclusive adaptation of vertebrates and enables rapid propagation of
action potentials along axons. The myelin sheath, produced by Schwann cells in the PNS and
oligodendrocytes in the CNS, consists of membrane extensions tightly wrapped around axons
(Figure 1A). Schwann cells myelinate single axonal segments (internodes; Figure 1B,
arrowheads) whereas oligodendrocytes form multiple myelin internodes. Between adjacent
internodes are the unmyelinated nodes of Ranvier where voltage-sensitive ion channels are
concentrated (Figure 1B, asterisk). The myelin sheath is an electrically insulating sheath that
promotes rapid propagation of action potentials along axons preventing current flow across the
axonal internodal membranes and thereby focuses depolarization produced by action potentials
on nodes of Ranvier. An action potential starts with the depolarization of the nodal membrane
due to the influx of sodium ions through voltage sensitive sodium channels and is followed by
closing and inactivation of sodium channels and the exit of potassium ions for repolarization.
The influx of sodium ions depolarizes downstream nodes enabling the action potential to move
from node to node in a saltatory manner (Figure 1C). As sodium channels are inactivated for a
short time after activation, the action potential is propagated in a unidirectional manner. The
conduction velocity of myelinated axons is up to 100m/sec. To achieve similar velocities,
unmyelinated axons would require 100 times larger diameters.
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Figure 1 (A) Cross section through a myelinated axon of the peripheral nervous system.
Electron microscopy. Axon (Ax), compact myelin (m), basal lamina (bl), extracellular collagen
fibrils (c), cytoplasm (asterisk), periaxonal and abaxonal membrane (arrows). Close up: compact
myelin membranes. Major dense line (MDL), intraperiod line (IPL). (B) In vitro myelinating DRG
(dorsal root ganglia) cultures. Nodes of Ranvier (asterisks), myelinated internodes (arrowheads).
Staining: (red) myelin basic protein (MBP) (compact myelin); (green) myelin associated
glycoprotein (MAG) (periaxonal membranes and paranodal regions). (C) Myelination facilitates
rapid propagation of axon potentials, which jump from node to node.
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2 The architecture and biochemical composition of the myelin sheath
Myelinated internodes mainly consist of compact myelin that appears electron microscopically as
a lamellar structure of alternating dark (major dense line, MDL) and light lines (intraperiod line,
IPL) that spiral around the axon. Dark lines represent the condensed intracellular, light lines the
extracellular space (Figure 1A, close up, Figure 2A). Membranes of the compact myelin show a
unique biochemical composition with about 75% lipids and 25% proteins with mainly adhesive
function. Myelin lipids include cholesterols, phospholipids and glycosphingolipids. The protein
compositions of myelin sheaths differ in the PNS and CNS. Abundant proteins include P0
(Lemke and Axel, 1985), the myelin basic proteins (MBP) (Staugaitis et al., 1996) and PMP22 in
the PNS and proteolipid protein (PLP) and MBP in the CNS myelin (Snipes et al., 1992; Boison et
al., 1995). P0, PMP22 and PLP are integral membrane proteins and are important for the
maintenance of both, the extracellular and cytoplasmic spacing of myelin membranes (myelin
periodicity).
At the lateral ends of the myelin internodes, myelin membranes remain uncompacted and are
fixed as loops to the paranodal axonal region. Important molecules for the maintenance of the
nodal architecture is for instance neurofascin 155 inserted into the paranodal glial loops acting
as binding partner of the axonal paranodin/Caspr-contactin complex (Figure 2A and B; (Charles
et al., 2002)).
Other uncompacted myelin compartments exclusively found in the PNS are funnel-shaped
incisures spanning through the myelin sheath. The functional role of so called Schmidt-
Lanterman incisures has not been defined yet. However, they may provide a shortcut for
communication between the outer and inner aspects of the myelin internode (Figure 2C, D).
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Figure 2 (A) Schematic view of a myelinated internode in the CNS. Unwrapped myelin sheath
with compact and uncompact compartments. Paranodal loops are uncompacted and attached
to the axons (for instance via caspr/contactin and neurofascin interaction). OL: oligodendrocyte;
Ax: axon. (B) Ultrastructure of a node of Ranvier. Ax: axon, M: myelin. (C, D) Schmidt-
Lanterman incisure: uncompacted Schwann cell membranes spanning through the myelin
sheath (arrow). Ax: axon, M: myelin (Copied from Lazzarini R. A. , 2004).
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3 Schwann cell development and myelination
The Schwann cell lineage originates from the neural crest cells. Neural crest cells give rise to
Schwann cell precursors that develop into immature Schwann cells that differentiate in two
types of mature Schwann cells, the myelinating and non-myelinating Schwann cells (Figure 3).
Non-myelinating cells surround multiple axons and form Remak bundles, whereas myelinating
Schwann cells form a multilammelar myelin sheath around individual axons. Differentiation of
Schwann cells critically depends on signals provided by the associated axons. Whether a
particular Schwann cell will differentiate into a myelinating or a non-myelinating Schwann cell
depends on the amount of type III neuregulin-1 present on the associated axons; low levels are
required for ensheathment by non-myelinating cells whereas high levels induce myelination
(Chan et al., 2004; Taveggia et al., 2005). Neuregulin is recognized by the Schwann cells via a
receptor tyrosine kinase composed of a ErbB2/ErbB3 heterodimer.
Promyelinating Schwann cells destined to myelinate axons establish a one to one relationship
with the axons and cease to proliferate, but remain capable of entering the cell cycle, a property
important in adult regeneration (Zorick and Lemke, 1996). The myelination program in Schwann
cells is characterized by the expression of specific transcription factor genes like SCIP and Krox-
20. SCIP is important for the correct onset of myelination, whereas Krox-20 is required for
proper ensheathment and expression of genes encoding myelin proteins (Topilko et al., 1994;
Weinstein et al., 1995). Prior the onset of myelination, Schwann cells polarize their surfaces into
the abaxonal and periaxonal membranes. The abaxonal membrane directs the production of a
basal lamina, a prerequisite for myelination (Bunge et al., 1986). The basal lamina contains
laminin 2, type IV collagens, fibronectin, N-syndecan, and glypican. The periaxonal membrane is
in direct contact with the axonal membrane via cell adhesion molecules such as N-cadherin, L1
and MAG, the myelin-associated glycoprotein (Seilheimer et al., 1989; Owens et al., 1990b;
Wanner and Wood, 2002). The spiral growth of the membrane is initiated by the expansion of
membranes at the edges of the Schwann cells. The precise process of the wrapping is not well
understood. Once several spiral turns are formed, the cytoplasm between the membranes is
extruded and the extracellular space decreased. The conversion of non-compact myelin to
compact myelin coincides with the occurrence of P0, the major structural protein of the
compact PNS myelin, and disappearance of MAG in the mesaxonal membrane, which is finally
exclusively found in periaxonal membranes (Trapp, 1988). The myelin sheath thickness is
correlated to axon diameter and is probably regulated by the amount of NRG1-III expressed by
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the axons. It is suggested that neurons regulate the expression of NRG1 as a function of their
own dimension (Michailov et al., 2004). The cellular mechanisms that regulate the length of
myelinated internodes are not known. However, studies have shown that disruption of
cytoplasmic bands called Cajal bands impairs Schwann cell elongation. Therefore it has been
proposed that internodal growth is permitted by microtubule-based transport along the
longitudinal bands of Cajal (Court et al., 2004).
Figure 3 (A) The development of the Schwann cell lineage: neuronal precursor cells give rise to
Schwann cell precursor cells that differentiate into immature Schwann cells. From immature
Schwann cells two Schwann cell subtypes evolve: the non-myelinating and the myelinating
Schwann cells. Differentiation of the Schwann cells is marked by morphological changes and
the appearance of characteristic differentiation markers and is reversible (Copied from Lazzarini
R. A. , 2004).
4 Oligodendrocyte development and myelination
Oligodendroglial progenitor cells arise from cells of the subventricular zone. The migrating
progenitor cells proliferate and populate the nervous system during development. They pass
through early and late progenitor stages marked by stellate shapes and develop into
premyelinating oligodendrocytes or adult progenitors (Figure 4). All progenitor oligodendrocytes
express the patelet derived growth factor receptor α (PDGFαR) and the sulfated proteoglycan,
NG2 (Pringle et al., 1992; Nishiyama et al., 1996). Premyelinating oligodendrocytes show
radially and symmetrically extended processes and express a subset of myelin proteins such as
DM20, MAG, CNPase and MBP. In contrast to Schwann cells, oligodendrocytes do not require
axonal contact to initiate myelin protein expression. Premyelinating oligodendrocytes either start
General Introduction
15
myelination or undergo programmed cell death. It has been estimated that about 50% of
oligodendrocytes undergo apoptosis (Barres et al., 1992). Differentiation of premyelinating
oligodendrocytes to myelinating oligodendrocytes includes morphological and molecular
changes. As myelination begins, oligodendrocytes start to target myelin proteins to specific
membrane domains requiring a complex network of microtubules. MAG is confined to the
periaxonal membranes, PLP, MBP and MOG to the compact myelin, CNP to non-compact
regions of the myelin internodes. MBP RNA is translocated along oligodendrocytes processes
and translated into protein (Colman et al., 1982). In contrast to Schwann cells, oligodendrocytes
have the potential to myelinate multiple axons.
Figure 4 The development of the oligodendrocyte lineage: Oligodendrocyte progenitor cells
migrate from the subventricular zone (SVZ) to the developing white and gray matter and They
give rise to premyelinating oligodendrocytes and adult progenitor cells. Premyelinating
oligodendrocytes either myelinate axons or undergo programmed cell death (Copied from
Lazzarini R. A. , 2004).
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5 Myelin proteins
The following paragraphs provide background information about a series of myelin proteins.
The proteins are described in more detail because they are abundant myelin proteins or because
they are of particular importance in this work.
5.1 Myelin basic protein (MBP)
Myelin basic protein is an abundant myelin protein found in the CNS as well as in the PNS. The
MBP gene contains three transcription starts that give rise to three different RNAs. The classic
MBP isoform expressed by myelinating Schwann cells and oligodendrocytes are generated from
the major transcription start site 3. From transcription start site 1, the so-called golli-MBP
proteins are generated. Golli-MBP proteins are expressed in the thymus, the spleen and the
lymph nodes and only at low levels in the nervous system. At least six alternatively spliced MBP
RNAs generated from transcription start site 3 have been documented that encode MBP
isoforms that range from 14 to 21kD. The proportions of the different MBP isoforms are
developmentally regulated. Early during development, the 17 and 21.5kD isoforms
predominate, whereas the proportion of the 14 and 18.5kD isoforms increase later during
development.
The main biological function of the classic MBP is to maintain the structure of the myelin
sheath. It has been suggested that the highly positively charged MBP interacts with the
negatively charged cytoplasmic membrane surface and brings thereby the layers of myelin in a
close position (Harauz et al., 2004). The precise roles of the different MBP isoforms are not
clear. Mice with mutated MBP protein (shiverer mice) caused by a deletion within the MBP gene
show a severe phenotype that is marked by a generalized tremor (Roach et al., 1985). In the
CNS of shiverer mice, there is an almost complete lack of myelin and the oligodendrocyte
membranes do not compact to form a major dense line. In the PNS in contrast, compact myelin
is formed in shiverer mice and myelin periodicity is normal (Rosenbluth, 1980). It is thought that
other myelin proteins such as P0 compensate for the loss of MBP in the PNS (Martini et al.,
1995).
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5.2 Proteolipid protein (PLP)
PLP and its smaller isoform DM20 are the most abundant myelin proteins predominantly
expressed in CNS. The PLP gene locus comprises 7 exons and DM20 is produced through
alternative splicing of exon 3. DM20 is the predominant isoform early during oligodendrocyte
development. PLP is a hydrophobic protein with four α-helical membrane spanning domains
with both amino and carboxy termini exposed to the cytoplasm. DM20 has identical amino acid
sequences as PLP at the amino and carboxyl termini, but it lacks about 40 amino acids of the
cytoplasmic domain. The hydrophobicity of PLP and DM20 is increased by posttranslational
covalent linkage of long chain fatty acids (Messier and Bizzozero, 2000). A PLP mutant mouse
the so-called jimpy mouse shows a myelin deficiency restricted to the CNS due to an aberrant
RNA splicing of PLP (Nave et al., 1987).
5.3  Myelin oligodendrocyte protein (MOG)
MOG is a glycoprotein specifically expressed by oligodendrocytes. It is only a minor component
of the CNS myelin. It is a transmembrane protein with an extracellular Ig-like domain and the
intracellular domain is possibly semi-embedded in the cytosolic side of the membrane. MOG is
localized in the abaxonal myelin membrane. Its localization suggests that it could interact with
molecules of the extracellular matrix or that it may be involved in adhesion between
neighboring myelinated fibers, possibly via homophilic MOG-MOG interaction. The expression
of MOG is one of the latest events during CNS myelination. MOG knock out mice develop
normally and there are no apparent effects on the myelin morphology (Delarasse et al., 2003).
MOG is a major target for autoantibody-mediated demyelination in experimental autoimmune
encephalomyelitis (EAE), an animal model for multiple sclerosis (MS).
5.4 Protein zero (P0)
P0 is the most abundant myelin protein of the PNS. It is an integral membrane protein and is
important for myelin compaction. P0 belongs to the immunoglobulin gene superfamily and has
a disulfide-stabilized VH domain and a single transmembrane domain. Post-translational
modifications of P0 include glycosylation of the extracellular domain with a complex
carbohydrate and acylation and phosphorylation of the intracellular domain. It is proposed that
P0 form tetramer complexes and that these complexes of opposing membrane layers interact
via homophilic interaction. P0 is primarily expressed by Schwann cells and mutations of P0 are
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associated with the peripheral neuropathy Charcot Marie Tooth 1B. For the induction and
maintenance of P0 expression, Schwann cells require contact with axons.
5.5 Myelin associated glycoprotein (MAG)
Myelin-associated glycoprotein is an immunoglobulin-like cell adhesion molecule. It shows five
Ig-like domains and belongs to the sialic acid binding protein family siglec 4a (Arquint et al.,
1987; Crocker et al., 1998). MAG is expressed by myelinating Schwann cells and
oligodendrocytes. MAG is located in the periaxonal membrane of glial cells and is suggested to
play an important role for axon-glia interaction (Figure 5A; (Bartsch et al., 1989)). MAG is also
located in compartments of the non-compact myelin such as Schmidt-Lanterman incisures and
paranodal loops (Owens and Bunge, 1989). It exists in two isoforms whose expression is
regulated spatially and temporally. The isoforms result from alternative splicing and show
common extracellular and different intracellular domains (Lai et al., 1987). The MAG gene
consists of 13 exons (Figure 5B). Exon 12 can be alternatively spliced in, or skipped, to produce
the small isoform (S-MAG, 67kD) or large isoform (L-MAG, 72kD), respectively. L-MAG
predominates during CNS development, whereas S-MAG accumulates later. In the PNS, the S-
MAG is the predominant isoform (Inuzuka et al., 1991). The alternative splicing of MAG is
regulated by the RNA binding protein QKI-5 (Wu et al., 2002). Mice with a naturally occurring
mutation within the regulatory region of the QKI gene show a predominant S-MAG expression
during development and reduced L-MAG levels.
MAG undergoes a variety of post-translational modifications such as phosphorylation,
glycosylation and palmitylation. Potential phosphorylation sites within the cytoplasmic domains
are Serine, Threonine and Tyrosine residues (Agrawal et al., 1990). Possible kinases involved in
the phosphorylation of MAG are PKA, PKC and Fyn (Jaramillo et al., 1994). Fyn kinase, a
member from the Src family of tyrosine kinases, has been shown to interact with the L-MAG
cytoplasmic domain. MAG is heavily glycosylated mostly by oligosaccharides of the complex
type. Eight N-linked oligosaccharide addition sites have been identified (Burger et al., 1993). A
high proportion of the oligosaccharides are sialylated and sulphated. One carbohydrate epitope
expressed on MAG as well as other cell adhesion molecules such as N-CAM, L1 and P0 is called
HNK-1 (Kruse et al., 1984; Bollensen et al., 1988). Auto-antibodies to MAG commonly react
with the HNK-1 epitope and can cause chronic neuropathies involving neuronal degeneration or
demyelination (Ilyas et al., 1990).
General Introduction
19
Figure 5 (A) Localization of MAG. MAG is localized in the periaxonal membranes of myelinating
oligodendrocytes and Schwann cells. Electron microscopy with postembedding staining
technique. (Copied from (Bartsch et al., 1989)). (B) Intron/ exon structure of the MAG gene. The
MAG gene consists of 13 exons. Exon 12 is spliced in to produce S-MAG (Copied from Lazzarini
R. A. , 2004).
Several axonal MAG binding partners have been described. Among them are gangliosides (sialic
acid containing glycosphingolipids) GD1a and GT1b (CNS) (Yang et al., 1996a; Schnaar et al.,
1998). Mice lacking the biosynthesis of complex gangliosides show a similar phenotype as MAG
knock out mice (Sheikh et al., 1999). MAG/gangliosides signaling pathways possibly regulate
neurite outgrowth. MAG may inhibit neurite outgrowth via multivalent clustering of
gangliosides on neurons (Vyas et al., 2002). Apart from gangliosides, the Nogo receptor NgR is
proposed to bind MAG (Liu et al., 2002). Nogo receptors are thought to mediate the inhibition
of axonal outgrowth by binding MAG, OMgp or Nogo in the CNS. As signal transducing
coreceptor for gangliosides and NgRs low affinity neurotrophin receptor p75 has been
suggested (Wang et al., 2002a; Yamashita et al., 2002b). Microtubule associated protein 1B
(MAP1B) is described as an additional MAG binding partner that is expressed at the surface of
axonal membranes (Franzen et al., 2001). MAG has also been shown to interact with
components of the extracellular matrix such as collagen, tenascin-R and fibronectin (Probstmeier
et al., 1992; Yang et al., 1999).
MAG isoforms show different signaling capacities due to their diverse intracellular domains.
Cross-linking of L-MAG has been shown to activate Fyn that phosphorylates a tyrosine residue
on the L-MAG domain. Phosphorylated L-MAG associates with phospholipase Cγ and may serve
as docking site for other signaling molecules (Jaramillo et al., 1994; Umemori et al., 1994). L-
MAG also interacts with the cytoplasmic protein S100β, a calcium- and zinc-binding protein
(Kursula et al., 1999). S100β  interacts with a variety of cytoskeleton associated proteins,
A B
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including actin microfilaments, microtubules, and intermediate filaments. The S-MAG specific
domain has been shown to bind tubulin and microtubules (Kursula et al., 2001).
The functional role of MAG has been studied in vitro as well as in vivo. In vitro it has been
shown that MAG overexpression correlates with accelerated myelination, whereas MAG
downregulation correlates with hypomyelination (Owens et al., 1990b; Owens and Bunge,
1991). MAG-deficient mice show only a subtle phenotype with slight defects in myelin
formation and maintenance that mainly affects the CNS. In the CNS in contrast to the PNS,
myelination is delayed in MAG deficient mice (Montag et al., 1994; Bartsch et al., 1997). In the
CNS and less often in the PNS, the periaxonal cytoplasmic collars are collapsed (Montag et al.,
1994). In the CNS of MAG-deficient mice, axonal segments are often surrounded by more than
one myelin sheath and in old animals oligodendrocyte dystrophy is observed resembling dying-
back oligodendrogliopathy (Lassmann et al., 1997). In the PNS of older MAG-deficient mice,
alterations such as redundant myelin layers called “onion bulbs” that indicate repeatitive de-
and remyelination are observed (Fruttiger et al., 1995). MAG-deficient mice show generally
reduced axonal calibers and more densely packed neurofilaments (Yin et al., 1998). Old MAG-
deficient mice show reduced nerve conduction velocities.
5.6 Peripheral myelin protein (PMP22)
The peripheral myelin protein PMP22 is an integral membrane protein widely expressed in
neural and non-neural tissue (Baechner et al., 1995). The expression of the PMP22-gene is
controlled by two different promoters P1 and P2 (Suter et al., 1994). P1 regulates PMP22
expression in Schwann cells and is activated specifically by progesterone (Desarnaud et al.,
1998). P2 is more ubiquitously active. PMP22 is strongly expressed in Schwann cells at the
beginning of myelination. It is localized in the plasma membranes of non-myelinating and
myelinating Schwann cells and the compact myelin (Haney et al., 1996). There is a rapid
turnover of PMP22, only a minor proportion of the newly synthesized PMP22 gets glycosylated,
accumulates in the Golgi apparatus and is integrated into myelin (Pareek et al., 1993). PMP22 is
a tetraspan transmembrane protein with a predicted molecular weight of 18kD. PMP22 runs as
22kD protein on denaturating SDS gels due to glycosylation. It has been proposed to be
associated with the tetrameric complex of the compact myelin protein P0 (D'Urso et al., 1999).
Changes of the stoichiometry of P0 and PMP22 are likely to affect the ordered structure of
myelin and are associated with peripheral neuropathies. Duplication of the PMP22 gene leads to
an overexpression of PMP22 causing the peripheral neuropathy CMT1A (Charcot Marie Tooth
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disease type 1A). The reciprocal intrachromosomal deletion of PMP22 is associated with the
hereditary neuropathy with liability to pressure palsies (HNPP). The functional role of PMP22 has
been studied in cells in vitro as well as in vivo. In vitro studies have shown that PMP22 is
induced by growth arrest of NIH3T3 cells after serum deprivation (Ciccarelli et al., 1990).
Functional experiments have also shown that PMP22 overexpression in NIH3T3 induces
apoptosis (Fabbretti et al., 1995). PMP22-deficient mice show a retardation in the onset of
myelination and develop abundant sausage-like hypermyelination structures (tomacula) at a
young age followed by severe demyelination, axonal loss and functional impairment (Adlkofer
et al., 1995). Mice carrying a PMP22 point mutation the so called trembler mice display a severe
hypomyelination during early development and only few myelinated fibers (Suter et al., 1992).
5.7 Connexin29 and Connexin32 (Cx29, Cx32)
Connexins are a family of highly related proteins and are named according to their predicted
molecular weights. Connexins belong to the gap junction proteins that provide direct diffusion
pathways of small molecules and are expressed by multiple cell types. In the CNS, Cx29 is
localized to the inner membrane of small myelin sheaths, whereas Cx32 is localized on the outer
membrane of large myelin sheaths (Kleopa et al., 2004). In the PNS, Cx29 and Cx32 protein
have been demonstrated at paranodal loops and Schmidt-Lanterman incisures, and it is widely
assumed that Connexins present in these locations provide a direct radial route for transport of
ions and metabolites between cytoplasmic myelin layers (Balice-Gordon et al., 1998; Li et al.,
2002; Meier et al., 2004). The importance of gap junctions is demonstrated by the fact that
mutations in Cx32 are associated with X-linked peripheral neuropathy Charcot-Marie-Tooth
disease (CMTX) (Fairweather et al., 1994).
6 Inherited peripheral neuropathies
Originally, hereditary motor and sensory neuropathies (HMSN) also called Charcot-Marie-Tooth
diseases (CMT) have been classified according to their clinical, electrophysiological and
histological characteristics into primary demyelinating (CMT1) and primary axonal forms (CMT2).
Demyelinating forms are usually marked by an early onset (first or second decade of life),
segmental demyelination, remyelination and nerve conduction velocities (NCV) below 38 m/s.
Axonal forms generally show a later onset (third or fourth decade of life), loss of myelinated
axons and NCV above 38 m/s. During the last years molecular and cellular mechanisms
underlying the pathologies of CMT diseases have been studied and variety of CMT subclasses
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has been formed (Table 1). Known genetic defects causing de- and dysmyelinating subtypes
affect structural myelin proteins, transcription factors and proteins for protein synthesis,
transport and degradation in Schwann cells. Axonal neuropathies are caused by defects in
motor proteins, protein transport or proteins of the axonal cytoskeleton.
Table 1 Classification of peripheral CMT neuropathies and their inheritance (copied from
(Berger et al., 2006))
Protein Synonyms Disease Inheritance
Myelin structure
P0
PMP22
Cx32
Periaxin
MPZ
PASII, SR13, Gas3
GJP1
PRX
CMT1B
CMT1A
X-linked CMT
CMT4F
Dominant
Dominant
X-linked
Recessive
Transcription factors
EGR2 Krox-20 CMT1D/CMT4E Dominant/ recessive
Vesicular transport
MTMR2
MTMR13
Dynamin2
SIMPLE
SBF2
DYN2
LITAF
CMT4B1
CMT4B2
DI-CMTB
CMT1C
Recessive
Recessive
Dominant
Dominant
Others
KIF1B
GDAP1
YARS
NDRG1
KIAA1985
NF-L
CMT2A
CMT4A
DI-CMTC
CMT4D
CMT4C
CMT2E
Dominant
Recessive
Dominant
Recessive
Recessive
Dominant
6.1 CMT1A is caused by a duplication of the structural protein PMP22
CMT1A is the most common inherited peripheral neuropathy and is caused by the duplication
of the gene encoding the structural protein PMP22 (Skre, 1974). Duplication of PMP22 results
in an overexpression of PMP22. The precise mechanisms underlying the disease are still not
clearly known. It is hypothesized that PMP22 and P0, which are both sensitive to gene-dosage
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and physically interact with each other, are required in precise stoichiometric amounts. It has
also been shown that overexpression of PMP22 disturbs Schwann cell maturation and causes
metabolic disturbances as PMP22 aggregates and blocks protein degradation by the
proteasome (Magyar et al., 1996; Notterpek et al., 1999). A variety of animal models has been
generated to study the mechanisms of CMT1A disease. There are rat and mouse models for
CMT1A disease carrying PMP22 genes from human, rat or murine origin.
The CMT1A rat model
The CMT1A rat model was generated using a 43 kb cosmid containing the mouse PMP22 gene
including flanking DNA regions (Sereda et al., 1996). The CMT1A rat carries approximately 3
copies of the PMP22 gene that leads to a 1.6 fold PMP22 overexpression. Many axons have only
thin or absent myelin sheaths. Supernumerary Schwann cell processes, so called “onion bulbs”
that indicate repetitive demyelination and remyelination are occasionally observed in CMT1A
rats. Motor fibers are more severely affected than sensory fibers. Hypomyelination is generally
more marked in larger caliber fibers. In CMT1A rats, axonal loss is observed. Many smaller fibers
have myelin sheaths of normal or even increased thickness.
The CMT1A mouse models: TgN248 and TgN249
The TgN248 and TgN249 CMT1A animal models were generated using the same 43 kb PMP22
containing cosmid used for the rat model described above (Magyar et al., 1996). The TgN248
mouse carries 16 and the TgN249 30 transgene copies. The expression of PMP22 RNA is
approximately 2 fold increased. Both lines display a severe demyelinating phenotype
characterized by an almost complete lack of myelin. In both lines, numbers of Schwann cells
associated 1:1 with axons as at the promyelination state are increased. Onion bulbs are not
observed in TgN248 and TgN249.
The CMT1A mouse model: M41
The M41 mouse line was generated using a YAC construct containing the mouse PMP22 gene
with flanking DNA regions (Robertson et al., 2002). Neither the copy number nor the levels of
PMP22 RNA have been determined yet in M41 mice. M41 mice have a severe demyelinating
phenotype. About 75% of the axons have no or only a thin myelin sheath. Myelinated fibers
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show an increased g-ratio (axon diameter/ diameter of myelinated fiber) of 0.74 compared to
controls (0.65). In M41 mice, the myelin periodicity is normal and there is no evidence for
axonal loss. However, the fiber size distribution shows a lack of large myelinated fibers. The
numbers of Schwann cells are increased in M41 mice, which is a general characteristic in
demyelinated nerves. Onion bulbs are not observed in M41 mice.
The CMT1A mouse model: C61and C22
The C61and C22 mouse lines were generated using a YAC construct containing the human
PMP22 gene with flanking DNA regions (Huxley et al., 1996).
The C61 mouse line carries 4 copies of the human PMP22 gene. C61 mice have a mild
demyelinating phenotype. Only about 3.1% of the axons are dysmyelinated. The g-ratios,
myelin periodicity and numbers of Schwann cells are normal in C61 mice. In C61 mice, there is
no evidence for axonal loss. There is a decreased proportion of large myelinated fibers and an
increased proportion of small caliber myelinated fibers.
The C22 mouse line was used in the study presented here. It carries about 7 copies of the
PMP22 gene resulting in a 1.7 fold expression of PMP22. The resulting peripheral neuropathy
closely resembles the human pathology of CMT1A disease. The characteristics of C22 mice are
the progressive weakness of the hind legs and severe hypomyelination (Figure 6A, B). The sciatic
nerves display widespread hypomyelination of medium to large axons, but no signs of acute
axonal degeneration (Huxley et al., 1996). C22 mice show very slow nerve conduction velocities
and prolonged distal motor latencies (MCV 3.7 +/- 2.2m/s in C22; 38.2 +/- 6.3m/s in wild type)
(Huxley et al., 1998). C22 have decreased numbers of myelinated fibers during development
and in adulthood. Only about 60% of axons are myelinated in adults. Numbers of incompletely
surrounded axons during development and in the adult C22 mice are increased. Numbers of
Schwann cells per axons are significantly increased in C22 mice at all time points (adult C22
mice: 12.3 Schwann cell nuclei/100 axons; wild type 4.4) (Robertson et al., 1999). The analysis
of the fiber size distribution in C22 mice revealed decreased numbers of large myelinated fibers
and an increase in the proportion of smaller ones. The average of the g-ratio is significantly
increased in C22 indicating inappropriately thin myelin sheaths. The myelin periodicity showed a
significant increase in the C22 nerves (Robertson et al., 2002). C22 mice were used in preclinical
trials to test the therapeutic efficacy of ascorbic acid that is known to promote Schwann cell
differentiation. Ascorbic acid treatment resulted in amelioration of the CMT1A phenotype
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improving locomotion and increased the numbers of myelinated axons from 25% (placebo
control animals) to 70% (ascorbic acid treated animals). Myelin sheath thickness was returned
to normal in ascorbic acid treated animals, which indicates that it may reactivate the myelination
process. Measurement of PMP22 RNA levels revealed a 10 fold decreased expression in ascorbic
acid treated mice (Passage et al., 2004).
Figure 6 (A) The PMP22 transgenic mouse C22. C22 mice progressively lose control of the hind
legs end up with a severe disability. (B) Light microscopic histology of the sciatic nerve (C22)
shows a widespread demyelination of axons in C22 animals (Copied from Huxley et al., 1996).
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6.2 CMT1D is caused by mutations of the transcription factor EGR2/Krox20
CMT1D is a demyelinating neuropathy caused by mutation of the Schwann cell transcription
factor EGR2/Krox20. Mutations are located within the zinc finger domain of EGR2/Krox20
causing a severe form of CMT. It is hypothesized that the expression of compact myelin protein
P0 and also lipid synthesis is controlled via EGR2/Krox20 (Nagarajan et al., 2001).
6.3 CMT2A is caused by mutation of the motor protein kinesin
CMT2A is primary axonal neuropathy caused by a mutation within the motor protein kinesin 1B.
Kinesins are molecules that transport vesicles along microtubules by hydrolyzing ATP. It is not
clear which of the two isoforms of KIF1B is affected in CMT2A patients. The pathology of
CMT2A is length dependent reflecting that distal nerves are primarily affected by impaired
kinesin dependent transport (Zhao et al., 2001).
6.4 CMT2E is caused by mutation of the neurofilament light chain
CMT2E is another axonal form of CMT. It is caused by mutations within the gene encoding the
neurofilament light chain. Neurofilaments are the major components of the axonal
cytoskeleton. In animal with mutations in neurofilament light chain, axonal diameters are
reduced which probably accounts for slowed nerve conduction velocities (Jordanova et al.,
2003).
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7 Neurofilaments, the major components of the axonal cytoskeleton
Various neurodegenerative diseases such as Amyotrophic lateral sclerosis, Alzheimer’s,
Parkinson’s and CMT disease are characterized by alterations in the axonal cytoskeleton.
Alterations especially affect neurofilaments which are therefore commonly used as surrogate
markers for axonal injury (Petzold, 2005). Neurofilaments make up the majority of scaffolding
proteins of the axonal cytoskeleton. They are classified as type IV intermediate filaments.
Neurofilaments are obligate heteropolymers that are composed of three subunits, a light (NF-L),
a medium (NF-M) and a heavy chain (NF-H). During development, NF-L and NF-M are
coexpressed initially whereas NF-H appears later (Carden et al., 1987). All neurofilament
subunits consist of an amino-terminal head domain, a central conserved rod domain and a
carboxy-terminal tail domain. The neurofilament subunits form dimers, which are sorted in an
antiparallel fashion to form tetramers. Tetramers combine to protofilaments, which finally
assemble into 10nm thick filaments. Assembly of neurofilament subunits in filaments is probably
regulated by the phosphorylation of the NF-L head domain as phosphorylation of the NF-L head
domain inhibits the formation of protofibrils (Hisanaga et al., 1990). The tail domains of NF-M
and especially NF-H can be heavily phosphorylated at lysine-serine-proline (KSP) sites.
Phosphorylation of neurofilaments is thought to be controlled by the process of myelination and
is regulated by a kinase/phosphatase system. Different kinases are implicated into neurofilament
tail phosphorylation such as glycogen synthetase kinase-3, extracellular signal-regulated kinases
and cyclin-dependent kinase 5 (Guidato et al., 1996; Veeranna et al., 1998). Neurofilament tail
phosphorylation is proposed to increase the distances between neighboring neurofilaments and
to be associated with an increase in axonal caliber (Hsieh et al., 1994). However, it seems that
NF-M and NF-H stoichiometrics are more important for axonal growth than NF-H
phosphorylation (Xu et al., 1996). In addition, phosphorylation of neurofilament tail domains
has been suggested to regulate axonal transport. Recent studies suggest that the fast axonal
transport motor kinesin participates in neurofilament transport. It has been proposed that
phosphorylation of the neurofilaments promotes the dissociation of neurofilaments from the
motor protein kinesin and the formation of a macro-structure that cannot readily undergo
axonal transport (Jung et al., 2000; Yabe et al., 2000).
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Figure 7 Neurofilament subunits and assembly. (A) Neurofilament light, medium and heavy
chains. The subunits share a conserved core and head domain and differ in their tail domains.
The tails differ in length and can be phosphorylated at multiple KSP (Lys-Ser-Pro) repeats by
proline directed kinases (GSK-3, ERK1/2, Cdk5). (B) Neurofilaments form dimers that are sorted
in an antiparallel fashion and arrange to tetramers. Assembled tetramers form protofilaments
which finally build 10nm thick neurofilaments. (C) Electron microscopy of assembled
neurofilaments (Copied from Petzold, 2005).
A
B
C
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7.1 Transgenic and knock out animals generated to study the neurofilament system
Multiple mouse models have been generated to determine the specific roles of the
neurofilament subunit composition and the neurofilament phosphorylation in the establishment
and maintenance of the neurofilament network. In the following paragraphs the phenotypes of
different neurofilament animal models are shortly described.
To study the role of the neurofilament subunit composition, transgenic mice have been
generated that overexpress an individual neurofilament subunit (Xu et al., 1996). It has been
shown that the increase of the NF-H, NF-M or NF-L subunit alone inhibits radial growth, while
increasing both NF-M and NF-H reduces axonal growth even more severely. In contrast, a
combined increase of NF-L with either NF-M or NF-H promotes radial growth. Neurofilament
subunit composition also determines the number of neurofilaments. Overexpression of NF-L
increases neurofilament the numbers, whereas overexpression of NF-M and NF-H reduces the
numbers. Neither the inhibition nor the enhancement of axonal growth correlates with changes
of the neurofilament neighbor distances in these transgenic mice (Table 2).
The hypothesis that the neurofilament tail phosphorylation of the NF-H specifies axonal growth
has been tested by two independent groups using NF-H null mutant mice (Elder et al., 1998b;
Rao et al., 1998). The outcome of the two studies is conflicting. The study presented by Rao et
al. shows that in the absence of NF-H, levels of NF-M undergo a compensatory increase. In their
mouse model, the absence of NF-H shows little effect on the radial axonal growth. The number
of neurofilaments is normal and the nearest neighbor distances only slightly reduced. Elder et al.
showed that in the absence of NF-H, NF-M levels are not changed and the levels of NF-L only
slightly reduced. In their mouse model, the absence of NF-H diminishes axonal calibers. The
number of neurofilaments is slightly reduced and the nearest neighbor distances not
significantly changed. Both studies do not provide evidence that the nearest neighbor distances
of neurofilaments are determined by phosphorylation of the NF-H tail domain.
In further studies, the role of NF-M for axonal growth has been analyzed (Elder et al., 1998a;
Rao et al., 2003). According to Elder et al., the absence of NF-M dramatically decreases levels of
NF-L and increases levels of NF-H. They have shown that in the absence of NF-M, axon calibers
as well as numbers of neurofilaments are diminished. Rao et al. specifically deleted the carboxy-
terminal tail domain of the NF-M using a gene knock-in approach. They have shown that
mutation of the NF-M tail domain severely inhibits radial axonal growth and reduces the nearest
neighbor distances between neurofilaments.
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A neurofilament deficient strain of the Japanese quail, named quiver (Quv), has been
informative of the functional role of the neurofilament light chain (Yamasaki et al., 1991). In
Quiver animals, neurofilaments are electron microscopically and immunohistochemically not
detectable in the axons or neuronal cell bodies. In Quiver animals, axons are composed mainly
of microtubules, which are increased in number in relation to the axonal size. Molecular
biological analyses have shown that the expression of neurofilament-L gene is specifically
repressed in neurons of this mutant. The fact that in the absence of NF-L neurofilaments are not
produced indicates that the NF-L subunit plays a key role in assembly of the NF subunits. In
Quiver animals, the size distribution of the axonal calibers significantly shifted to small size
classes.
Table 2 Phenotypes of different neurofilament animal models
Animal model Axonal phenotype (PNS, L5 ventral root) Reference
Overexpression of
NF-L
NF-M
NF-H
NF-H/M
NF-L/M
NF-L/H
Axon diameter
↓
↓
↓
↓↓
↑
↑
NND
↓
–
–
clustered
↓
–
Levels of (Xu et al., 1996)
NF-H knock out (↓) – NF-M ↑
NF-L –
(Rao et al., 1998)
NF-H knock out ↓ (↓) NF-M –
NF-L (↓)
(Elder et al., 1998b)
NF-M knock out ↓ ↑ NF-H ↑
NF-L ↓
(Elder et al., 1998a)
NF-MΔtail ↓ ↓ NF-H –
NF-L –
(Rao et al., 2003)
Quiver (Japanese
quail)
↓ Almost depleted (Yamasaki et al.,
1991)
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7.2 Modulation of neurofilaments by myelination
Evidence that myelination has an impact on the properties especially the phosphorylation of
neurofilaments is given by several studies. Starr et al. have performed experiments in vitro with
dorsal root ganglion (DRG) Schwann cell co-cultures and have shown that phosphorylation of
neurofilaments is regulated by myelination (Starr et al., 1996). They have analyzed the
phosphorylation state of neurofilaments in DRG neurons cultured in the presence (myelinated)
and absence (unmyelinated) of ascorbic acid and have found that myelination induces an
increased immunoreactivity for phosphorylated neurofilament epitopes. In addition, they have
detected an increased kinase activity in myelinated cultures compared to unmyelinated ones.
The relationship between neurofilament phosphorylation and myelination has also been
investigated by Hsieh et al. and Mata et al. (Mata et al., 1992; Hsieh et al., 1994). They have
studied the distribution of phosphorylated and non-phosphorylated neurofilaments along the
axons of myelinated fibers. Their results have indicated that the degree of phosphorylation of
the neurofilament heavy and medium chains is reduced in unmyelinated regions such as the
nodes of Ranvier and the stem processes in comparison with internodal neurofilaments.
The impact of myelination on the neurofilament system has also been studied in various mouse
models that present a demyelinating phenotype. De Waegh et al. have shown that axon
calibers, neurofilament phosphorylation and spacings are locally controlled by myelinating
Schwann cells (de Waegh and Brady, 1990; de Waegh et al., 1992). In their experimental set up
they grafted nerve segments from Trembler mice (point mutation in PMP22) in control sciatic
nerves and compared axon diameters, neurofilament phosphorylation and spacing in grafted
segments nerve segments to adjacent regions. They have found reduced axonal calibers,
decreased neurofilament phosphorylation and neurofilament spacings in grafted nerve
segments.
Cole et al. have studied the consequences of peripheral nerve hypomyelination on the axon
diameter, neurofilament phosphorylation and neurofilament density (Cole et al., 1994). For their
study they used transgenic mice with a demyelinating phenotype caused by the expression of
diphtheria toxin or SV40 controlled by the P0 promoter in Schwann cells. They have found that
severe hypomyelination is associated with a decrease in axonal caliber, a dramatic decrease of
phosphorylation and an increase in neurofilament density. From their studies they have
concluded that signals transmitted by myelinating Schwann cells modulate axon calibers,
neurofilament phosphorylation and neurofilament density.
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That myelination regulates the neurofilament phosphorylation has been well established and
suggests that Schwann cell-axon interactions act to modulate a kinase-phosphatase cycle
responsible for maintaining the phosphorylation state of neurofilaments in normal nerve.
However, the precise signal transduction pathways have not been determined yet. De Waegh et
al. have suggested MAG as logical candidate for the Schwann cell ligand to axonal receptor (de
Waegh et al., 1992). They have proposed MAG as signaling molecule on the Schwann cell side
of the pathway simply due to its localization at the myelin-axon interface. First experimental
evidence that supports a functional role for MAG in the regulation of axonal calibers,
neurofilament phosphorylation and spacing has been provided by Yin et al. (Yin et al., 1998).
Their study has shown that the absence of MAG correlates with reduced axonal calibers,
reduced neurofilament phosphorylation and neurofilament spacing. That these changes are
indeed due to the absence of MAG and not a secondary effect of a generally disrupted
Schwann cell-axon junction that prevents signaling by other molecules has been demonstrated
in vitro by Dashiell et al. (Dashiell et al., 2002). They have shown that phosphorylation of
neurofilaments is increased in DRG neurons cultured with MAG transfected COS-7 cells as well
as in PC12 neurons treated with soluble MAG-Fc. In addition, they have shown that MAG
stimulates the activities of Cdk5 and ERK1/2 kinases.
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Aim of the project
The formation and maintenance of myelinated nerves requires constant reciprocal signaling
between glial cells and axons. However, little is known about the molecules that mediate axon-
glial interactions at the onset and during maintenance of the myelin sheath. One molecule
implicated in the axon-glial interaction is the myelin-associated glycoprotein (MAG). MAG is
expressed early at the onset of myelination when glial cells attach to axons and is still present in
the periaxonal membranes after spiral enwrapping and compaction. MAG is expressed as a
large (L-MAG) and a small isoform (S-MAG) that display different intracellular domains that
cannot be distinguished by antibody staining. The precise functional role of the two MAG
isoforms is not known. The purpose of the first part of this thesis was investigation of the
temporal and spatial expression pattern of L- and S-MAG isoforms in the CNS and PNS. For this
study a transgenic mouse expressing GFP tagged S-MAG controlled by its own promoter was
generated by Michael Erb (Erb, 2003) and handed over for detailed characterization. The initial
question was whether the introduction of transgene somehow interferes with normal
myelination or even with the correct localization of S-MAG in the myelin compartments. Then
the isoform specific expression pattern of MAG within different structures of the brain, within
different domains of the myelin sheath during development and in adults was investigated.
Charcot-Marie-Tooth disease type 1A is the most frequent hereditary peripheral neuropathy
caused by duplication of a DNA region encoding peripheral myelin protein PMP22. The impact
of the overexpression of PMP22 on Schwann cells has been well described. The aim of the
second part of this thesis was to investigate whether PMP22 overexpression may have an effect
on the development of myelinated axons in CMT1A disease as consequence of disrupted
Schwann cells/axons signaling. Indications that abnormal Schwann cells have an impact on
axons originally came from transplantation experiments, where allografts from Trembler-mice
(point-mutation in PMP22) were used as bridges to connect the proximal and distal stumps of
transected nerves from normal mice. Regenerating axons penetrating the allograft showed
reduced calibers, higher neurofilament density, and a low phosphorylation state, alterations that
were restored in the distal host-derived part of the nerve containing wild type Schwann cells (de
Waegh et al., 1992). In this work, the developmental effect of PMP22 overexpression on the
establishment and maintenance of the axonal cytoskeleton in an animal model for CMT1A
disease was investigated with focus on the neurofilament subunit composition and
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phosphorylation. A further aim was to investigate the expression of MAG under these
conditions.
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The expression of myelin-associated glycoprotein isoforms in CNS and
PNS (Part I)
Michael Erb*, Bettina Flueck*, Frances Kern, Beat Erne, Andreas J. Steck, and Nicole Schaeren-
Wiemers
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The following section is based on the work published in Molecular and Cellular Neuroscience,
“Unraveling the differential expression of the two isoforms of myelin-associated glycoprotein in
a mouse expressing GFP-tagged S-MAG specifically regulated and targeted into the different
myelin compartments” (April 2006, Volume 31, Pages 613-627). The part “Materials and
Methods” was extended.
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1 Abstract
The two myelin-associated glycoprotein (MAG) isoforms are cell adhesion molecules that differ
only in their cytoplasmic domains, but their specific roles are not well understood. In this study,
we present a transgenic mouse line that specifically expresses GFP-tagged S-MAG correctly
regulated and targeted into the myelin sheath allowing the specific discrimination of L- and S-
MAG on the subcellular level. Here, we describe the differential expression pattern and spatial
distribution of L-and S-MAG during development as well as in the adult central and peripheral
nervous system. In peripheral nerves, where S-MAG is the sole isoform, we observed S-MAG
concentrated in different ring-like structures such as periaxonal and abaxonal rings, and discs
spanning through the compact myelin sheath perpendicular to the axon. In summary, our data
provide new insights in the subcellular distribution of the two isoforms fundamental for the
understanding of their specific functions in myelin formation and maintenance.
2 Introduction
For accurate action potential propagation along myelinated axons, the adhesive contacts
between the axons and the myelin sheaths and between the myelin lamellae are essential. One
adhesion molecule, which is implicated in the interaction between the axon and the myelinating
cell during myelinogenesis and maintenance, is the myelin-associated glycoprotein (MAG). MAG
is located in the myelin membranes juxtaposed to the axon and on apposing myelin membranes
in the non-compact myelin compartments like the Schmidt-Lanterman incisures and the
paranodal loops (Sternberger et al., 1979; Trapp and Quarles, 1982; Martini and Schachner,
1988; Trapp et al., 1989). As an axonal binding partner of MAG, MAP1B expressed as plasma
membrane glycoprotein on neurons and the NgR2 have been suggested (Franzen et al., 2001;
Venkatesh et al., 2005). MAG has also been shown to interact with the sialylated gangliosides
GD1a and GT1b (Yang et al., 1996b; Vinson et al., 2001a; Vyas and Schnaar, 2001). Beside its
adhesive properties, MAG plays also a role in axon-glia signaling, since the axon caliber of
peripheral myelinated fibers of MAG-deficient mice is reduced due to decreased neurofilament
phosphorylation, which seems to be mediated in a Cdk5 and Erk-dependent manner (Dashiell et
al., 2002). MAG is also known as one of the molecules that impairs axonal regeneration
(Venkatesh et al., 2005).
The functional role of MAG is mediated by the two individual intracellular domains of the two
MAG isoforms: L-MAG (large) and S-MAG (small). The non-receptor tyrosine kinase Fyn has
been identified as a signaling molecule downstream of L-MAG (Umemori et al., 1994). Beside
Fyn, the calcium binding protein S100β and the phospholipase Cγ have been shown to be
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isoform specific binding partners of L-MAG (Jaramillo et al., 1994; Kursula et al., 1999). These
observations point to the functional roles for L-MAG in signal transduction and adhesion in
axon-glia and/or glia-glia interactions. The S-MAG specific domain has been reported to bind to
tubulin and microtubules, supporting a role for S-MAG as a cell adhesion molecule linking the
axonal surface and the myelinating glial cell cytoskeleton (Kursula et al., 2001).
To address the differential expression of L- and S-MAG within the non-compact myelin domains
and within individual fiber tracts, we have generated a transgenic mouse line that specifically
expresses the S-MAG isoform tagged with green fluorescent protein (GFP) as S-MAG-GFP fusion
protein. Here, we report the subcellular compartmentalization of S-MAG-GFP within the myelin
sheath; among them are ring- or and disk-like structures in the PNS, and paranodal loops in the
CNS and PNS. Furthermore, we describe the differential expression of L- and S-MAG during
development and in adult myelinated fibers.
3 Materials and Methods (Part I)
3.1 DNA construct
To generate the pmag-MAG-e12GFP genomic expression construct encoding S-MAG-GFP
fusion protein, the 19 kb C57Bl mouse MAG gene, including 1.8 kb promoter and all
introns/exons was used. Briefly, the GFP sequence was inserted in front of the stop codon
within exon 12 (Figure 1A) as described in detail before (Erb et al., 2003). The pmag-MAG-
e12GFP sequence was excised from pBluescript with SalI and NotI. The insert was separated
from the cloning vector by agarose gel electrophoresis using TAE buffer at 4 °C. The DNA was
purified from the agarose gel using the GENECLEAN SPIN Kit (Q-BIO gene/Bio 101) and was
further purified using the ELUTIP-D-COLUMN-SET (Schleicher&Schuell).
3.2 Generation of transgenic mice
Standard pronuclear injection procedures were used (performed by Dr. C. Goujet-Zalc, CNRS-
UPS44, Villejuif-Paris, France). Transgenic animals were identified by PCR genotyping of tail
DNA. From the two born founder animals, one transmitted the transgene. This founder animal
was further bred with C57BL6. The transgene copy numbers were analyzed by quantitative real-
time PCR (Q-PCR). On genomic DNA samples from wild type and transgenic mice, a 140 bp
intron sequence of the mag gene (equally present on the endogenous mag gene and the
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transgenic mag gene copies) was amplified together with a 200 bp sequence of the neurofascin
gene. The mag gene levels obtained from the Q-PCR analysis were normalized to the
neurofascin gene levels (internal standard). The normalized mag gene level obtained for wild
type samples corresponds to the 2 endogenous mag gene copies. The normalized mag gene
levels of transgenic animals were divided by the ones of wild type animals. This ratio
corresponds to the x-fold presence of 2 mag gene copies in a transgenic animal. Therefore, this
ratio was multiplied by 2 to obtain the single mag gene copy number (endogenous and
transgenic), from which the 2 endogenous mag gene copies had to be subtracted to get the
transgenic mag gene copy number ((mag-tgnormNF / mag-wtnormNF) x 2 – 2).
The genomic DNA was isolated from a tail specimen using the DNeasy tissue kit (Qiagen) and
the Q-PCR was carried out using the Roche LightCycler together with the FastStart DNA Master
SybrGreenI (Roche). The 140 bp intron sequence of the mag gene (endogenous and transgenic)
was amplified using 5’MAGgen (5’-GCTGGGAATGCTGATGTTGTG-3’) and 3’MAGgen (5’-
TGGGGAAGGAAGGGAATGGTAG-3’). The 200 bp intron sequence of the neurofascin gene
was amplified, using 5’NFgen (5’-AGAGGAAATGAGGCAACGGG-3’) and 3’NFgen (5’-
GCTGGAATGGGAGGGGAATAAG-3’).
3.3 PCR and quantitative real-time PCR
RNA was isolated using guanidine thiocyanate as described before (Chomczynski and Sacchi,
1987). First strand cDNA synthesis was performed with Transcriptor Reverse Transcriptase
(Roche) and Oligo (dT)15 Primer (Promega Corporation, Madison, USA). To amplify the MAG
mRNA region of exon 10 to 13, the primer pair 5’exon10 (5’-GTCGCCTTTGCCATCCTGATT-3’)
and 3’exon13 (5’-TCTCAGATCCCAGGCGCTG-3’) was used. Q-PCR was carried out using the
Roche LightCycler with the FastStart DNA Master SybrGreenI (Roche). Primers were designed by
using MacVector (Accelrys GmbH, Germany) and were used as the following:
For total MAG: 5’totalMAG (5’-GTTTGCCCCCATAATCCTTCTG-3’) and 3’totalMAG (5’-
TCCCTCTCCGTCTCATTCACAGTC-3’);
For L-MAG: 5’L/S-MAG (5’-AATCGGTCCTGTGGGTGCTG-3’) and 3’L-MAG-exon11/13 (5’-
CGCTGCTTCTCACTCTCATAC-3’);
For wild-type S-MAG: 5’L/S-MAG and 3’S-MAG-exon12 (5’-GGGGCTCTCAGTGACAATCC-3’);
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For PLP/DM20: 5’PLP/DM20 (5’-ACTGTTGTATGGCTCCTGGTGTTTG-3’) and 3’PLP/DM20 (5’-
GCGAAGTTGTAAGTGGCAGCAATC-3’);
For MBP: 5’MBP (5’-GGTCCAGGCTTCCTTTGTTTTCTTC-3’) and 3’MBP (5’-
TGTCCAGCGTGTTCTCCTAAGTCC-3’);
For P0: 5’P0 (5’-GGTGACCCTGCACTGCTC-3’) and 3’P0 (5’-GCAACAGCACCACCCCGA-3’);
For actin: 5’Actin (5’-GGAAATCGTGCGTGACATCAAAG-3’) and 3’Actin (5’-
CATACCCAAGAAGGAAGGCTGG-3’).
cDNA copy numbers for each gene were quantified by using standard curves of known
quantities of plasmids containing the corresponding PCR product. The cDNA copy numbers
were normalized to actin expression levels. In all analyzed transgenic tissues, no surplus L-MAG
mRNA was detected. This is in line with in vitro data of the present MAG transgene, which
showed that L-MAG is not transcribed from this transgene (Erb et al., 2003).
Quantification of mRNA levels in brain tissues was performed with three animals from each
genotype independently. For quantification of mRNA levels in sciatic nerve tissues, sciatic nerves
from 5 animals from each genotype were pooled and three experiments were performed
independently.
3.4 Western blotting
Brain and sciatic nerve myelin membrane purification
Myelin was isolated from fresh frozen tissue via a sucrose gradient preparation. One brain was
homogenized in 3 ml buffer containing 250 mM sucrose, 10 mM Hepes, 2 mM EGTA pH7.4
and protease inhibitors aprotinin (1 µg/ml), leupeptin (2 µg/ml), pepstatin (1 µg/ml) and PMSF
(100 µg/ml) (buffer A). Tissue was homogenized with a 12 mm polytron for 2 times for 10 sec
and always kept on ice. The homogenate was centrifuged at 2000 rpm for 3 min at 4 °C in SW
rotor. The supernatant was collected and adjusted to a volume of 3.2 ml with buffer A. Then
5.8 ml buffer containing 2 M sucrose, 10 mM Hepes, 2 mM EGTA pH 7.4 (buffer C) were
added and mixed by rotation for 5 min (final sucrose concentration in the mixture was 1.4 M).
The sucrose gradient was set up in 14 ml Beckman 14x95 mm Polyallomer tube as follows: 1.1
ml buffer C (2 M sucrose), 8.5 ml homogenate (1.4 M sucrose), 2.2 ml buffer B (0.85 M
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sucrose), 0.75 ml 0.25 M. The gradient was centrifuged for 20 h at 25000 rpm at 4 °C in a TST-
4114 swing out with a Centrikon T-1055 ultracentrifuge. The myelin and plasma membrane
phases accumulated in the 250 mM and 850 mM sucrose phases were collected in 15 ml tube
using a spatula or a pipette. The collected samples were homogenized ones in 4 ml Hepes, 2
mM EGTA pH 7.4 with a 12 mm polytron and the volume was adjusted to 14 ml. The
homogenates were centrifuged at 25000 rpm for 3 h at 4 °C. The supernatant was discarded
and the pellet resuspended in 200-500 µl water and stored at –80 °C.
Myelin protein quantification
Protein concentrations were determined by Bradford assay. Myelin samples were diluted 1:10,
1: 20 and 1:40 (duplicates) and a BSA standard dilution series was prepared (100, 200, 400,
600 and 800 ng/µ l BSA). 20 µ l sample and 200 µ l Bradford reagent were mixed, the
absorbance at 590 nm was measured and concentrations calculated.
SDS-PAGE/Western blotting
Gels were prepared according to Laemmli protocol (Laemmli, 1970). Resolving gels contained 8
or 15% acrylamide/Bis (Biorad), 375 mM Tris pH8.8 and 0.1% SDS and was polymerized with
50 µl 10% ammonium persulfate (Biorad) and 5 µl TEMED (Biorad) per 10 ml gel. The stacking
gels contained 5% Acrylamide/Bis, 125 mM Tris pH6.8 and 0.1% SDS and was polymerized
with 50 µl 10% APS and 10 µl TEMED per 10 ml gel. The 4x sample buffer contained 40%
glycerol, 8% SDS, 0.5% bromphenol blue, 80 mM Tris pH 6.8 and 20% β-mercaptoethanol
(Sigma). Samples were heated for 30 min at 37 °C for denaturation. The running gel buffer
contained 25 mM Tris-base (Riedel de Haen) 14.4% glycine (Riedel-de Haen) and 1% SDS. The
gels were run overnight at 15 V. Prior protein transfer, gels were washed in running gel buffer
and then equilibrated in transfer buffer (25 mM Tris-base, 14,4% glycine). The proteins were
transferred to PVDF membranes (Biorad) at 50 V for 1.5 h. Blots were then washed in TBST (500
mM NaCl, 20 mM Tris pH 7.5 and 0.05% Tween20 (Fluka)) and incubated in with either 3%
TopBlock (JuroSupply GmBH) in TBST (ECL detection system) or Odyssey blocking reagent
(Odyssey detection system) for 3 h at RT. Primary antibodies were incubated overnight at 4 °C in
either 1% TopBlock buffer or Odyssey blocking reagent (diluted 1:1 with TBS). Blots were
washed 3 times in TBST for 20 min prior incubation with secondary antibodies. Peroxidase
coupled secondary antibodies were used for ECL detection, fluorescence coupled ones for the
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Odyssey detection. After incubation with secondary antibodies, blots were washed three times
in TBST (15 min) and ones in TBS (5 min). Bands were detected with the ECL Western Blotting
Detection Reagents (Amersham Pharmacia) and exposed to Hyperfilm ECL (Amersham
Pharmacia). Fluorescent bands were detected with Odyssey Infrared Imager from LI-COR
Biosciences GmbH, Germany (Hornig and Uhlmann, 2004; Williamson et al., 2004).
To quantify endogenous MAG levels, myelin samples were analyzed simultaneously with MAG
and CNPase specific antibodies. We compared the MAG signals normalized to CNPase an
internal standard protein in brains from 7 transgenic and 5 wild type animals in 4 independent
experiments. Sciatic nerves from 5 animals of each genotype were pooled and quantified in 3
independent experiments.
Primary antibodies: anti-L-MAG (polyclonal, 1:500; (Erb et al., 2003), anti-MAG (polyclonal,
1:5000; kindly provided by Dr. A. Heape, Oulu, Finland), anti-CNPase (monoclonal, 1:1000,
SMI91; Sternberger).
Secondary antibodies: goat anti-mouse IgG peroxidase (1:20000) and goat anti-rabbit IgG-
peroxidase (1:5000) (Jackson ImmunoResearch), goat anti-mouse Alexa Fluor 680 (1:10000) and
goat anti-rabbit IRDye 800 (1:10000) (LI-COR Biosciences GmbH, Germany).
3.5 Immunohistochemistry
Staining of brain and sciatic nerve sections
Brain and sciatic nerves were embedded in Tissue-Tek O. C. T. Compound (Sakura) without
prior fixation. Cryostat sections of fresh frozen tissue (10 µm) were mounted on gelatine-
chromalaun-coated slides. Sections were fixed in 10% formalin, 0.08 M phosphate buffer
pH7.1 for 3 h. For delipidation slides were incubated overnight in 70% ethanol. Slides were
washed in PBS (15 min). Before peroxidase staining, endogenous peroxidase activity was
prevented with 0.6% H2O2 in 80% methanol for 20 min and washed in PBS (15 min).
Unspecific binding sites were blocked for at least 1 h in blocking buffer (2.5% normal goat
serum (Jackson ImmunoResearch), 0.1% fish skin gelatin (Sigma), 0.05% Saponin (Sigma) in
PBS (Frank et al., 1998). Slides were incubated with primary antibodies in blocking buffer at 4
°C for 48 h, washed for 15 min in PBS and detection performed either with the ABC Kit (Vector
Laboratories) or fluorochrome labeled secondary antibodies at RT for 30 min. The peroxidase
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reaction was performed with AEC substrate as described before (Erne et al., 2002) and cell
bodies were counterstained weakly with Mayer’s Haemalaun (Merck) for 1 min. Kaisers’ glycerol
gelatine (Merck) was used for the embedding of the peroxidase stained slides, FluorSaveTM
Reagent (Calbiochem/Merck, Germany).
Preparation and staining of sciatic nerve teased fibers
Teased fibers were prepared from Zamboni fixed adult mouse sciatic nerves (De Martino and
Zamboni, 1967). Sciatic nerves were fixed for 15 min in Zamboni solution* and washed 2 times
in PBS for 15 min. For the preparation a binocular microscope was used. Sciatic nerves were put
in a drop of dH2O for preparation to avoid dehydration and cut into 1-2 mm pieces with
razorbills. Connective was removed with sharp needles, bundled axons were separated with
forceps and placed on gelatine chromalaun coated slides. The teased fiber samples were dried
at 37 °C for 1 h and stored at –20 °C. Teased fibers were postfixed and permeabilized in –20 °C
acetone for 10 min, blocked at RT for at least 1 h in PBS containing 4% normal goat serum, 1%
Glycine, 3% Triton X-100 and incubated with primary antibodies for 48 h at 4°C. Slides were
washed in PBS for 15 min, incubated with fluorochrome labeled antibodies for 30 min, washed
with PBS (15 min), rinsed with dH2O and embedded with FluorSaveTM.
*Zamboni solution: 4 g paraformaldehyde (Fluka) were solved in 30 ml Picric acid (Merck) at 60
°C for 1 h. 3-5 drops of 2.5% NaOH were added until the solution was clear. The solution was
cooled on ice, filtered and filled up to 200 ml with Soerenson phosphate buffer**. The
Zamboni solution can be stored at 4 °C up to 3 days.
**Soerenson phosphate buffer: 100ml Soerenson phosphate buffer contain 80.4 ml 0.4 M
Na2HPO4*2H2O, 19.6 ml 0.4M KH2PO4 and 138.6 mg glucose pH 7.4.
Culturing and staining of DRG explants
The DRG explant cultures were prepared as described by Kleitman et al. (Kleitman et al., 1998).
Embryos were sacrificed at embryonic day 13-13.5 (Time mating procedure is described below).
For the dissection and preparation a binocular microscope was used. Embryos were put into L15
medium (pH7.2-7.4, Sigma) for dissection. Embryos were decapitated and the vertebral column
and costal arch was laid open. From the ventral side, vertebrae were opened and removed from
the spinal cord. The DRGs were collected in an FBS coated 15 ml tube containing 1 ml MEM/10
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% FBS (MEM Gibco 31095-029, fetal horse serum Gibco). For dissociation DRGs were
centrifuged at 300 g for 5 min, resuspended in 1 ml 0.25% Trypsin-EDTA (Gibco) and
incubated at 37 °C, 5% CO2 for 45 min. Trypsin was inactivated with 3ml MEM/10% FBS. Then
the DRGs were centrifuged at 300 g, 5 min and resuspended 600 µl MEM/ 10% FBS/ 10 ng/ml
NGF (nerve growth factor Sigma N-1408) and triturated with FBS coated Pasteur pipettes. 150
µl were given on poly-L-lysine/collagen coated glass coverslips (Carenini et al., 1998). The DRGs
were cultured at 37 °C, 5% CO2. After 48 h, 600 µl MEM/ 10% FBS, 10 ng/ml NGF were
added. Medium was exchanged every 3-4 days. After one week, 50 µg/ml ascorbic acid (Sigma
A-4403) were added to the medium to induce myelination. After 4 to 5 weeks of culturing,
DRGs were used for immunohistochemistry. Slides were washed twice in PBS (10 min), fixed
with 4% paraformaldehyd for 15 min and washed 3x with PBS (15 min). For permeabilization,
slides were incubated with methanol (-20°C) (7 min for Caspr, 15 min for MBP staining). After
premeabilization, slides were washed twice (10 min) in PBS and blocked in with 5% bovine
serum albumin (Fluka), 1% goat serum and 0.2% Triton-X for 1 hour. Primary antibodies were
incubated overnight at 4 °C. After incubation with the primary antibodies, slides were washed 3
times in 0.2% Triton-X PBS (15 min) and incubated with secondary fluorochrome-labeled
antibodies. After 3 washing steps in 0.2% Triton-X PBS (15 min), slides were incubated with
Hoechst (1:100 in PBS) for 5 min and washed in dH2O prior embedding with Mowiol.
Mouse breeding: One male and one female mouse were kept in a cage separated by a partition
for 48 h. After 48 h the partition was removed for one night. The day after, females were
examined for plaques early in the morning. The day of plaque examination corresponded to
embryonic day 0 (E0).
Primary antibodies: anti-MBP (polyclonal, 1:2000; kindly provided by Dr. J.-M. Matthieu), anti-L-
MAG (polyclonal, 1:500; (Erb et al., 2003)), anti-MAG (monoclonal, recognizing both isoforms,
1:500, Boehringer Mannheim clone 513), anti-MAL (polyclonal, 1:200; (Schaeren-Wiemers et
al., 2004)), anti-PMP22 (polyclonal, 1:2000; kindly provided by Dr. U. Suter, ETH-Hönggerberg,
Zürich, Switzerland), anti-GFP (polyclonal, 1:2000; kindly provided by Dr. A. Matus, FMI, Basel,
Switzerland), anti-Caspr (polyclonal, 1:1000; kindly provided by Dr. E. Peles, Weizmann Institute
of Science, Rehovot, Israel), anti-Connexin29 (polyclonal, 1:2000; Zymed), anti-neurofilament
medium chain (polyclonal, 1:2000; Biomol Int.).
Secondary antibodies: goat anti-rabbit IgG-Cy3 1:500, Jackson Laboratories; goat anti-mouse
IgG-Cy5, 1:250, Jackson Laboratories.
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Light microscopy
Confocal fluorescence microscopy was performed on an inverted scanning confocal microscope
(LSM 510; Carl Zeiss MicroImaging, Inc.). For 3D reconstructions, data was processed with
Imaris software (Bitplane, Zürich, Switzerland). Transmission microscopy was performed on a
DMRE Leica microscope.
3.6 Electron microscopy
Buffers and solutions for EM embedding
0.2 M Cacodylate buffer: 42.8 g Sodium cacodylate trihydrate (Fluka) were solved in 800 ml
dH2O. The pH was adjusted to 7.4 with 1N HCl and 200 ml dH2O were added. The solution can
be stored at 4 °C for several of months.
2% Glutaraldehyde in Cacodylate buffer: 8 ml Glutaraldehyde solution (25%) (Fluka), 46 ml 0.2
M Cacodylate buffer pH7.4 and 46 ml dH2O. Solution can be stored up to 2 months at 4 °C.
Karnovsky solution: 3 g paraformaldyde were solved in 50 ml dH2O at 60-80 °C for 1 hour and
1-2 drops 1 N NaOH were added. The solution was cooled on ice, filtrated and mixed with 12
ml Glutaraldehyde solution (25%) and 38 ml 0.2 M Cacodylate buffer. Karnovsky solution
cannot be stored.
EM wash buffer: 500 ml EM wash buffer contain 2.5 g NaCl, 250 ml 0.2 M Cacodylate buffer
and 250 ml dH2O.
3% Kaliumferrocyanid II: Kaliumhexacyanoferrat (Merck) in 0.2 M Cacodylate buffer. Solution
can be stored at 4 °C.
EPON solution: 49 ml glycide-ether 100 (Merck), 16.7 ml DDSA (Dodecenylsuccinic anhydride,
Fluka) and 34.3 ml MNA (Methylnorbornene-2, 3-dicarboxylic acid, Fluka) were mixed and 2 ml
DMP-30 (2,4,6-Tris(dimethylaminomethyl)phenol, Fluka) were added to catalyze polymerization.
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Embedding of sciatic nerves
Tissue was taken from perfused animals (Karnovsky solution at RT for 20 min), incubated for 3 h
in Karnovsky solution and transferred in 2% Glutaraldehyde in Cacodylate buffer. Postfixation
with osmium tetroxide, dehydration, and EPON embedding were performed as described before
(Bartsch et al., 1995). Prior postfixation, tissue was washed 3 times (30, 30, 50 min) in EM wash
buffer at 4 °C. For postfixation, tissue was incubated for 3 h in 1% OsO4, 1.5% KFC, at 4 °C,
washed twice (30 and 60 min) in EM wash buffer at 4 °C and stored in EM wash buffer
overnight (18 h) at 4 °C. For dehydration tissue was incubated for 20 min (5, 5, 10 min) in 70%
ethanol at 4 °C, 15 min (5, 10 min) in 80% at 4°C, 15 min (5, 10 min) in 96% ethanol at RT
and 60 min (20, 20, 20 min) in absolute ethanol at RT. Then tissue was incubated in
propylenoxid (Fluka) for 60 min (10, 20, 30 min) at RT, in a propylenoxid-Epon solution mixture
(1:1) for 90 min at RT (Epon, Fluka) and for 21 h in propylenoxid-Epon solution mixture (1:3) at
RT. Then tissue was transferred to Epon solution. For prepolymerization, tissue was incubated at
37 °C for 2 h and for 24 h at 45 °C. For polymerization tissue was incubated 80 h at 65 °C.
Staining ultrathin sections of sciatic nerves
Ultrathin sections (70-80 nm) of the embedded tissue on 150 mesh grids were contrasted by
Uranyl-acetate (Fluka) and Pb-citrate (1.33 g Pb(Na3) (Merck) in 15 ml dH2O, 1.76 g
Na3C6H5O2*2H2O (Merck) in 15 ml dH2O , 8 ml 1N NaOH). For this, meshs were incubated for
45 min with Uranyl-acetate kept in the darkness and washed 4 times with water. Then they
were incubated with Pb-citrate for 6 min in a N2 chamber and washed 4 times with water.
Sections were imaged with a transmission electron microscope (Morgani 268D; Philips) with a
magnification of 7100x.
4 Results
4.1 Generation and validation of the S-MAG-GFP mouse line
To generate transgenic mice expressing the S-MAG isoform tagged as a GFP fusion protein, we
used the pmag-MAG-e12GFP genomic expression construct (Erb et al., 2003). This construct
allows correct regulation of the GFP-tagged S-MAG isoform, since it is driven by the mouse
MAG promoter and controlled by alternative splicing of all introns and exons. The GFP-sequence
was inserted in front of the stop codon within the S-MAG specific exon 12 (Figure 1A), leading
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to a GFP-S-MAG fusion protein with GFP fused to the intracellular and isoform specific C-
terminus of S-MAG (Figure 1E). The single founder animal has given spontaneously rise to two
separate and stable lines of high (∼33) and low (∼8) transgene copy numbers. All data presented
here are from the high copy number line. We amplified the exon 12 region of the MAG mRNA
from wild type and transgenic sciatic nerve and brain by RT-PCR using a single oligonucleotide
pair. The S-MAG-GFP mRNA was present in transgenic brain and sciatic nerve samples (Figure
1B). The S-MAG-GFP encoding mRNA runs at the expected position, showing the correct joining
of the modified exon 12 to its flanking exons 11 and 13. The endogenous L- and S-MAG
mRNAs levels in transgenic samples are unaltered when compared to the ones from wild type
samples.
On the protein level, the fusion of GFP (27 kDa) to the glycosylated S-MAG (105 kDa) leads to a
molecular weight of about 130 kDa. This is visualized as a second band running above wild type
L- and S-MAG in the Western blot analysis of adult brain and sciatic nerve myelin (Figure 1C).
Analysis of these myelin samples on a high percentage SDS-Page revealed low molecular MAG
bands of about 12, 15 and 40 kDa (Figure 1D). The 12 and 15 kDa bands correspond to the
endogenous membrane-associated-intracellular C-terminal domain of S- and L-MAG (S-MAGCT
and L-MAGCT), respectively, that result after cleavage of the extracellular domain of MAG
(soluble MAG also called dMAG, Figure 1E; (Moller, 1996; Stebbins et al., 1998; Paivalainen et
al., 2003). In the brain, both fragments of 12 and 15 kDa corresponding to both isoforms could
be detected with the anti-MAG antibody, whereas in sciatic nerve samples only the 12kDa
fragment of S-MAG could be detected (Figure 1D). Analysis with the anti-L-MAG specific
antiserum did only detect the 15 kDa fragment in the CNS, but not in the PNS (Figure 1D),
indicating that L-MAG is not expressed in adult peripheral myelin of mice. The 40 kDa fragment
was only detected in the transgenic brain and sciatic nerve myelin samples, representing the
cleaved S-MAG-GFP fragment, which consists of the 12k Da of wild type S-MAG and the 27
kDa GFP (Figure 1E). This 40 kDa product was also recognized by the anti-GFP antibody (data
not shown). From our data, we conclude that the proteolytic formation of intracellular MAG
fragments may be a regular process in vivo as myelin was isolated in the presence of protease
inhibitors, always kept at 4 °C and loaded without prior incubation. The proteolytic cleavage of
S-MAG seems to be more pronounced in the PNS, since the relative amount of S-MAGCT is
much higher compared to CNS (Figure 1D).
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Figure 1 Gene targeting and validation of the S-MAG-GFP mouse line. (A) Cloning strategy: the
EGFP sequence was inserted in front of the stop codon within the S-MAG C-terminus encoding
exon 12. The exon 12/intron 12 junction is flanked by two SmaI sites (A1). This fragment was
replaced by an identical sequence containing the EGFP in front of the exon 12 stop codon (A2).
The resulting mouse MAG gene clone (20 kb) contains all exons and introns and 1.8 kb of the
MAG promoter (pmag; A3). (B) The PCR amplification of the mouse MAG mRNA region
spanning exon 10 to 13 from 1-month-old wild type and transgenic brain and sciatic nerve,
produces a 184 bp product for L-MAG and a 229 bp for S-MAG, beside the 949 bp product for
S-MAG-GFP mRNA (229 bp of S-MAG + 720 bp of EGFP = 949 bp). The insertion of the GFP
encoding DNA seems not to affect the splicing process since no unexpected PCR product can be
detected. (C) Western blot analysis of 1-month-old brain and sciatic nerve myelin membranes
using a 8% SDS-PAGE revealed the S-MAG-GFP fusion protein of around 130-140 kDa above
the endogenous L-/S-MAG of around 110kDa. (D) Western blot analysis of myelin preparations
of 1-month-old brain and sciatic nerve wild type and transgenic animals using a 15% SDS-PAGE
revealed the presence of the 12 and 15 kDa endogenous and 40 kDa transgenic C-terminal
MAG fragments. In C and D, 1 µg of CNS and 5 µg of PNS myelin protein were analyzed. Note:
In C, the exposure time for PNS myelin was longer than for CNS. (E) A schematic representation
of the MAG isoforms, their putative cleavage products and the corresponding antibodies.
White boxes: non-coding exons; black boxes: coding exons; green boxes: EGFP DNA sequence;
pmag: MAG promoter H: HindIII; N: NotI; S: SmaI and S’: SalI.
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4.2 Expression of S-MAG-GFP does not interfere with endogenous L- and S-MAG
mRNA expression levels
To determine, if the expression of the S-MAG-GFP transgene has an impact on the endogenous
L- and S-MAG transcription and alternative splicing, we have analyzed the L-, S-MAG and S-
MAG-GFP mRNA levels by quantitative RT-PCR. These three different MAG transcripts were
amplified specifically from brain and sciatic nerve of wild type and transgenic mice at postnatal
day four (P4) and at one month (1mo). At postnatal day 4, L-MAG was the predominant
isoform in wild type and transgenic mice (Figure 2A). In the adult brain, S-MAG was expressed
at comparable levels as L-MAG (Figure 2C). The S-MAG-GFP and the endogenous S-MAG
mRNA showed an analogous expression pattern during development (Figure 2A) and in the
adult (Figure 2C). In sciatic nerves of wild type and transgenic mice, S-MAG and S-MAG-GFP
were the dominant isoform already at postnatal day 4 (Figure 2B), whereas only very low L-
MAG expression levels were detected at that stage. In the adult, endogenous S-MAG expression
was comparable in wild type and transgenic animals (Figure 2D), whereas the transgenic
expression of S-MAG-GFP was twice as much as the endogenous one. In contrast, L-MAG
expression was not detectable in the adult mouse sciatic nerve (Figure 2D). In summary, the
“additional” S-MAG-GFP mRNA expression did not affect the endogenous L- and S-MAG mRNA
expression levels in the CNS and PNS during development and in the adult. In addition, we
investigated the expression levels of the major myelin genes MBP, PLP/DM20 and P0 in parallel.
None of them showed any alterations in transgenic CNS and PNS tissues (data not shown),
demonstrating that transgenic S-MAG-GFP expression did not influence the expression pattern
of the major myelin genes.
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Figure 2 Quantitative analysis of the L- and S-MAG and S-MAG-GFP mRNA levels in CNS and
PNS. RT-PCR analysis of the endogenous L-, S-MAG and S-MAG-GFP mRNA levels was
performed at postnatal day 4 (A and B, P4) and at 1-month-old (C and D, 1mo) for brain (A and
C) and sciatic nerve tissues (B and D). The mRNA levels were normalized to the actin mRNA
levels. In the CNS, the levels of the S-MAG-GFP mRNA are comparable to the wild type S-MAG
mRNA levels, at P4 and 1mo. In the PNS, the S-MAG mRNA levels are increased by the presence
of the transgene to about 60% at P4 and 200% at 1-mo.
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4.3 Comparable expression levels of endogenous L- and S-MAG protein in the CNS
and PNS of transgenic and wild type animals
To determine whether the expression of additional S-MAG-GFP fusion protein influenced the
endogenous expression of L- and S-MAG, we quantified L-, S-MAG and S-MAG-GFP protein
levels by quantitative Western blot analysis, using an advanced infrared imaging system. Equal
amounts of brain myelin from 1-month-old mice were analyzed in parallel using the anti-MAG
antibody recognizing both isoforms (Figure 3A), or the anti-L-MAG specific antibody (Figure 3B).
The signal intensities of both endogenous MAG isoforms did not reveal any significant
difference between wild type and transgenic animals also when normalized with the one for
CNPase. Similarly, quantitative analysis of endogenous S-MAG levels in PNS myelin membrane
preparations showed that they were unaltered in transgenic compared to wild type mice (Figure
1D depicts one sample as an example). In parallel, we measured the relative amount of S-MAG-
GFP compared to endogenous L- and S-MAG, which was 0.28 (± 0.03), indicating a surplus
expression of about 30% S-MAG-GFP in brains of transgenic mice. In the PNS, the additional S-
MAG-GFP expression in transgenic mice led to an overall surplus S-MAG synthesis of about
100% (1.10 ± 0.08).
Figure 3 Quantification of L- and S-MAG
protein levels in the CNS of wild type
versus transgenic mice by infrared
imaging system.  The amounts of
endogenous L-/S-MAG and S-MAG-GFP in
brain myelin fractions of 1-month-old
animals were measured. A/B Western blot
analysis with an antibody recognizing
both MAG isoforms (specific to a
common intracellular domain) (A) and
only L-MAG (B) was performed with
myelin membrane preparations of brains
from transgenic (4 are depicted as
example) and wild type animals (2 are
depicted as an example). The amount of
CNPase protein served as equal loading
control. The endogenous MAG expression
in transgenic and wild type mice did not
show any difference.
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4.4 Differential expression pattern of L-and S-MAG during development
To investigate the developmental expression of the two MAG isoforms on a cellular level, we
performed an immunohistochemical analysis on transversal spinal cord sections at different
postnatal time points. The anti-MBP immunostaining indicated that the extent of myelination in
transgenic and wild type mice (Figure 4A, inset) was comparable. In the CNS, at postnatal day 4
(P4), L-MAG is already strongly expressed, both in the ventral and the dorsal funiculi (Fig 4B,
arrowheads), whereas S-MAG is only detectable in a small number of fibers in the ventral
funiculus (Figure 4C, arrowhead). The L-MAG expression followed by the expression of S-MAG
is also visualized on sagittal brainstem sections, where L-MAG is detected in oligodendrocyte
cell bodies at P4 (Figure 4H, arrows), and in their processes at P8 (Fig 4I, arrowheads), whereas
S-MAG was detected around P8 mainly in cell bodies (Fig 4J, arrow). In the PNS, S-MAG is the
predominant isoform and is already strongly expressed around birth. Figure 4G (arrow) depicts
S-MAG in ventral roots at P4. L-MAG, in contrast, is only detectable in distal nerves such as
whisker innervations and intercostal nerves (Figure 4F, lower panel, arrow) and could not be
detected in spinal roots (Figure 4E, arrow) at any time point during development (P0, P2, P4,
P10, data not shown). In a comparative study, we further analyzed the expression pattern of
several myelin proteins in transgenic and wild type mice by immunohistochemistry. We found a
comparable MBP (Figure 4A), MAL, MOG, PO and Periaxin expression pattern in transgenic and
wild type mice suggesting that the elevated S-MAG (S-MAG and S-MAG-GFP) levels did not
lead to alterations in myelin protein expression pattern (data not shown).
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Figure 4 Developmental expression pattern of L- and S-MAG
Immunohistochemical analysis was performed on transversal spinal cord sections of transgenic
animals at postnatal day 4 (A-H) and 8 (I, J) for MBP (A, D, F upper panel), L-MAG (B, E, F lower
panel, H and I) and for S-MAG-GFP (C, G, J). Insets in A and B show the expression pattern in
littermate wild type animals. In the spinal cord at P4 myelination is seen in dorsal and ventral
funiculus as detected by MBP (A) and shows a comparable pattern for L-MAG (B, arrowheads).
However, S-MAG-GFP expression is only detected in the ventral funiculus (C, arrowhead). In the
spinal roots myelination is also depicted by the strong expression of MBP (A and D, arrows) and
S-MAG-GFP (C and G, arrows), but L-MAG was absent (E, arrow). Still, some L-MAG positive
fibers could be detected in the intercostal nerves (F, upper panel), which were also MBP positive
(F, lower panel). H-J: Immunohistochemical analysis of sagittal brainstem section of a transgenic
mouse for L-MAG at P4 (H) and P8 (I) and for S-MAG-GFP at P8 (J), which were counter, stained
with Haemalaun (blue). Note, at P4 L-MAG is mainly expressed in oligodendrocyte cell bodies
(H, arrows), whereas at P8 strong expression in oligodendrocyte processes could be detected (I,
arrowheads). In contrast, S-MAG-GFP expression could be detected around P8, where it is
mainly localized in the oligodendrocyte cell bodies (arrow). Abbreviation: df, dorsal funiculus; vf,
ventral funiculus; DRG, dorsal root ganglion. Bars: A, B, C: 250 µm; F: 500 µm; H, I, J: 50 µm.
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4.5 Subcellular distribution of S-MAG in teased sciatic nerve fibers
S-MAG-GFP is localized in Schmidt-Lanterman incisures (Figure 5A and B, arrow) and periaxonal
membranes (Figure 5A and B, arrowheads) indicating a correct subcellular distribution of the
GFP-tagged MAG fusion protein. The S-MAG-GFP-autofluorescence signal is bright and clear
(Figure 5A, left panel) and is indistinguishable from an anti-GFP staining (Figure 5B, middle
panel). It was striking that the signal intensity of the periaxonal S-MAG-GFP in different fibers
varied strongly. Indeed, sciatic nerve cross sections revealed strong autofluorescence
predominantly in small caliber fibers (Figure 5C, arrowhead), whereas the autofluorescent signal
in large caliber fibers was weaker, in some cases not even detectable (Figure 5C, arrow).
Immunohistochemical analysis revealed an analogous expression pattern of endogenous MAG
in wild type mice (Figure 5 D).
In teased fibers, we observed frequently different ring- or disc-like structures where S-MAG-GFP
was accumulated. We observed periaxonal rings (Figure 6A, arrows), and rings surrounding
myelin sheath lamellae, probably within the abaxonal membrane (Figure 6A, arrowhead).
Another abundant ring-like structure appears as disc spanning perpendicular the whole
compact myelin sheath (Figure 6B, left panel, arrow; right panel 3D reconstruction). In search of
an ultrastructural correlate, we encountered zigzag shaped uncompacted incisures that might
reflect the discs seen at light microscopy (Figure 6C1, 6C2). Figure 6C3 depicts a “classical”
Schmidt-Lanterman incisure transversely through the myelin sheath in a funnel like fashion.
A colocalization study of MAG and the gap junction protein connexin 29 (Cx29), revealed a
nearly congruent expression pattern of both molecules not only in Schmidt-Lanterman incisures,
but also in the adaxonal membranes, and paranodal loops (Figure 6D, arrowheads). However,
while connexin 29 was strongly accumulated in both, the para- and juxtaparanodal region, S-
MAG-GFP was clearly concentrated at the paranodal and much less abundant in the
juxtaparanodal region of adult peripheral nerve fibers (Figure 6E, arrow).
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Figure 5 Localization of S-MAG-GFP autofluorescence peripheral nerve fibers
Colocalization study was performed on teased sciatic nerve fiber preparations (A) of 3-months-
old transgenic animals. S-MAG-GFP autofluorescence is shown in the left panels (green) and the
anti-GFP immunofluorescence in the middle panels (blue). The merged images (right panels)
indicate the overlapping expression. Note, that the distribution of the immunofluorescent signal
of the GFP-autofluorescence is comparable with the one of the anti-GFP-immunofluorescence.
Schmidt-Lanterman incisures (arrow), periaxonal membranes (arrowheads) B: High
magnification of S-MAG-GFP autofluorescence in Schmidt-Lanterman incisures (arrow) and in
periaxonal membranes (arrowheads). C: S-MAG-GFP autofluorescence (green) and anti-MAL
immunofluorescence (red, compact myelin) on sciatic nerve cross section of a transgenic animal.
D: anti-MAG (green) and anti-PMP22 (red, compact myelin) immunofluorescence on sciatic
nerve cross sections from a wild type mouse. Note, that MAG is mainly present in the small
myelinated fibers (arrowhead) and weakly expressed in the large caliber fibers (arrow). Bars: (A)
20 µm, (C, D) 25 µm.
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Figure 6 S-MAG-GFP localization in peripheral nerves
Confocal microscopy was performed on teased sciatic nerve fiber preparations of adult animals.
(A) S-MAG was detected in ring-like structures adjacent to the axon (arrows) and in discs
perpendicular to the axon (arrowhead). (B) An example for a disc-like structure spanning
through the myelin sheath (arrow) and “classical” Schmidt-Lanterman incisures is shown (red,
neurofilament, axon; green, S-MAG-GFP autofluorescence; blue, anti-MAG). Right panel: 3D
reconstruction of the disc (B, arrow) together with the neurofilament staining. The upper panel
shows a projection parallel to the axon and perpendicular to the disc, whereas the lower panel
shows the same some degrees turned to the front revealing that the disc spans the whole
myelin sheath. (C) EM analysis of longitudinal sciatic nerves of 6-month-old mice. Note, the
occurrence of zigzag shaped incisures (C1) and incisures spanning half of the myelin sheath
(C2). C3: classical Schmidt-Lanterman incisure with its funnel-shaped structure. (D)
Immunofluorescent colocalization study for connexin 29 (Cx29) and S-MAG-GFP
autofluorescence demonstrating the strong overlapping expression pattern (merge). (E) Intensity
profile through the node of Ranvier (D, arrowhead) showing the strong accumulation of Cx29
and S-MAG-GFP in the paranodes (arrowhead). In contrast, in the juxtaparanodal region (arrow)
only Cx29 could be detected. Bars: A: 10 µm; B: 3 µm; C: 2 µm; D: 20 µm.
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4.6 Differential L- and S-MAG expression in the brain
We analyzed the differential expression of L-and S-MAG in the adult brain. Overall analysis of
brainstem, cerebellum, midbrain and optic nerve showed an overlapping expression pattern of
both isoforms (data not shown). In certain forebrain regions, however, we found a differential
expression of L- and S-MAG. For instance, we detected strong S-MAG and MBP positive fibers
in the dorsal fornix (Figure 7A, arrow), which showed very low L-MAG expression (Figure 7B,
arrow). Also within the radiatum area of the corpus callosum, we detected strong S-MAG
positive fiber tracts that were also MBP positive (Figure 7C, arrow), but the L-MAG signal in
those fibers was only weak or even absent (Figure 7D, arrow). In contrast, fibers within the
truncus of the corpus callosum showed relative high levels of L-MAG (Figure 7B, arrowhead),
and other fiber tracts showed an even reciprocal L- and S-MAG expression (Figure 7E, arrow
points to an S-MAG-GFP positive fiber tract). In areas of the striatum and the hippocampus, it
was possible to discriminate fibers, which express both isoforms (Figure 7F, merge, yellow),
fibers, which express only S-MAG-GFP (Figure 7F, arrow) or fibers, which express preferentially
L-MAG (Figure 7F, arrowhead).
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Figure 7 Differential expression of L- and S-MAG in the mouse forebrain
Colocalization studies were performed on horizontal brain sections of 3-months-old transgenic
mice for S-MAG-GFP autofluorescence (green), MBP (A and C) and L-MAG (B, D, E and F). A, B:
S-MAG-GFP autofluorescence in the area of the contralateral projections of the corpus callosum
(cc) with the underlying dorsal fornix of both hemispheres (arrow) colocalized with MBP (A) and
L-MAG (B). Note, the strong autofluorescence of S-MAG-GFP and MBP expression in the dorsal
fornix, but weak expression of L-MAG. C, D, E: S-MAG-GFP autofluorescence in the adjacent
area of the corpus callosum, the radiatum colocalized with MBP (C) and L-MAG (D, E). E:
Confocal analysis of distinct fibers within the corpus callosum, which were strongly positive for
S-MAG-GFP (arrow), but L-MAG negative, whereas others vice versa. F: Confocal analysis of
myelinated fibers of the perforant pathway showing single S-MAG-GFP specific (arrow), L-MAG
specific (arrowhead) and fibers expressing both (merge, yellow).
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4.7 S-MAG accumulation in CNS paranodes
It is still unresolved whether MAG is localized in the paranodes of the CNS (Bartsch et al., 1989)
since its localization by immunofluorescence analysis was difficult due to technical limitation.
Therefore, we performed a confocal colocalization study on sagittal brain sections with the
paranodal marker Caspr. Generally, we could detect S-MAG-GFP autofluorescent signal
regularly in paranodes (Figure 8A1, A2, arrows), but the signal intensity was often relatively
moderate. This was confirmed by analyzing intensity profiles through a particular nerve fiber,
which revealed a colocalization of S-MAG-GFP autofluorescence and Caspr in the paranodes
(Fig 8A1 and A2, lower panels, arrows). Yet, there were also paranodes in which S-MAG-GFP
seemed not to be accumulated (Figure 8A3, see also intensity profile in the lower panel).
In contrast, in the PNS S-MAG-GFP accumulation was detected in all paranodes investigated
(Figure 8B). Sciatic nerve teased fiber preparations of 6-months-old animals revealed in a 3D
reconstruction an extended S-MAG-GFP immunofluorescent signal beyond the periaxonal
region (Figure 8B, arrow) supporting the idea that MAG is expressed between the paranodal
loops. Interestingly, S-MAG-GFP colocalized with Caspr throughout the paranode except for the
edge next to the node (Figure 8B, arrowhead). This feature has also been observed in an early
stage of myelination as depicted in in vitro myelinating DRG cocultures (Figure 8C, arrowhead).
In these cultures it became evident that S-MAG is strongly accumulated in the paranodal loops
during myelin formation (Figure 8D, arrow) and went in parallel to Caspr cluster formation (data
not shown).
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Figure 8 S-MAG expression paranodal loops in the CNS and PNS
A confocal analysis of different Nodes of Ranvier in sagittal brain sections and teased sciatic
nerve fiber preparations of 4-months-old transgenic mice with the paranodal marker Caspr was
performed. A: A series of Nodes of Ranvier (asterisk) in the hippocampal area are shown as
examples (upper panels). Intensity profiles in the lower panels demonstrate colocalization of S-
MAG-GFP autofluorescence with Caspr in the paranodes (A1 and A2, arrows). However, there
are also paranodes where S-MAG-GFP could not be detected (A3, arrow). B: S-MAG-GFP
autofluorescence in teased sciatic nerve fibers. Right panel shows a 3D-reconstruction of the S-
MAG-GFP accumulation in the paranodal loops (arrow). C, D: Myelinated axon in DRG explant
cocultures from a S-MAG-GFP mouse after 34 days in culture colocalized with Caspr (C, red),
and after 48 days with MBP (D, red) delineating the compact myelin sheath from the paranodal
region (arrow). Note, that S-MAG-GFP autofluorescence is strongly localized in the paranodes
and in periaxonal membranes. Bar: A, B, C, D: 5 µm.
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5 Discussion
In this study, we present a transgenic mouse line that expresses GFP-tagged S-MAG as a fusion
protein allowing the visualization of particular myelin compartment by autofluorescence. A
detailed molecular and cellular characterization during development and adult revealed that this
mouse line is comparable to wild type animals in all aspects tested such as gross anatomy and
myelinogenesis. This transgenic mouse line enabled us to analyze the differential expression
pattern and subcellular distribution of L- and S-MAG using the autofluorescence signal of S-
MAG-GFP together with an L-MAG specific antibody.
Almost complete absence of L-MAG in the mouse peripheral nervous system
Our analysis of the differential expression of L- and S-MAG in the mouse PNS revealed that S-
MAG is the predominant isoform. Both, on the mRNA levels as well as on the
immunohistochemical level, we found only traces of L-MAG during development, and in the
adult L-MAG was not detectable at all. Early during development L-MAG was only detected in a
subset of distal nerve fibers such as intercostal nerves and nerves innervating whiskers, but not
in proximal nerves such as spinal roots. The absence of L-MAG in the mouse PNS is in contrast
to the observation in humans (Miescher et al., 1997), and is comparable to studies in the rat,
where L-MAG could not be detected as well (Tropak et al., 1988; Noronha et al., 1989). Yet, in
vitro myelinating co-cultures of rat Schwann cells with purified sensory neurons revealed that L-
MAG could be transiently detected in nascent internodes (Owens et al., 1990a), which supports
our observation of L-MAG in a subset of internodes during early development. The negligible L-
MAG levels in the mouse PNS may explain the missing PNS phenotype of mice expressing
truncated L-MAG (Fujita et al., 1998) suggesting that L-MAG may not play a fundamental role
in PNS myelin. The functional role and significance of the transient and particular L-MAG
expression in mouse PNS myelinogenesis remains still elusive and needs further investigation.
Strong heterogeneity of S-MAG expression in PNS myelin sheaths
In peripheral nerves, we observed that periaxonal expression of S-MAG was predominantly in
small caliber fibers. Large myelinated fibers often show little and irregular periaxonal S-MAG
expression. This finding might explain that the reduced axon calibers found in MAG-deficient
mice did not have an affect on all fibers (Yin et al., 1998).
S-MAG expression and targeting
61
Beside the well-described localization of S-MAG in the adaxonal membrane, Schmidt-Lanterman
incisures and paranodes, we found S-MAG localized in ring- and disk-like structures including
the outer- and/or innermost myelin lamellae. We have summarized our observation about the
localization of S-MAG in the different compartments of the peripheral myelin sheath in a
schematic drawing (Figure 9A and B) and endeavored to associate the known MAG binding
partners within the different myelin compartments. The scheme depicts a peripheral myelin
sheath made by a Schwann cell but includes also components primarily known from the CNS
myelin. Periaxonal MAG possibly interacts with sialylated gangliosides, microtubule-associated
protein 1B (MAP1B) and members of the NgR receptor family maintaining a close interaction of
the Schwann cell and axon. In vitro studies have shown that MAG binds to certain glycan
structures prominently expressed on GD1a and GT1b gangliosides (Yang et al., 1996b; Vinson
et al., 2001a; Vyas and Schnaar, 2001), and as a signal transducing co-receptor the
neurotrophin receptor p75 was implicated (Yamashita et al., 2002a). The MAG-MAP1B
interaction has been proposed to be a structural link between the periaxonal membrane of the
myelinating cell and the axonal cytoskeleton (Franzen et al., 2001). Nogo-66 receptor (NgR1)
and the NgR1 related protein NgR2 possibly in association with p75 have been shown to
interact with MAG (Wang et al., 2002b; Wong et al., 2002; Lauren et al., 2003; Venkatesh et
al., 2005). Although the proteins of the NgR family are primarily known as an inhibitor of
axonal regeneration, it will be interesting to investigate whether it might also interact with MAG
under normal conditions stabilizing and maintaining the periaxonal interaction of the myelin
sheath with the axon. In the paranodal loops and the Schmidt-Lanterman incisures MAG might
stabilize the association of the outer myelin lamellae. The MAG-interacting components are not
identified so far, but one possibility could be by homophilic interaction (trans-interaction, Figure
9B), which is supported by its self-adhesive properties (Poltorak et al., 1987; Almazan et al.,
1992). We suggest that in the paranodal loops and in Schmidt-Lanterman incisures, the
compacted extracellular space may require a parallel orientation of the five Ig-loops between
the myelin lamellae (Figure 9B). One can imagine, for example, that two opposing MAG
molecules could interact with each other, maybe in a similar fashion as protein zero (P0).
Another possibility may be that the outer two Ig-like domains of MAG form a unit that folds
back over the rest of the molecule as suggested by Attia and collaborators (Attia et al., 1993).
The fact that there is no or only little widening of the extracellular space in uncompacted
compartments is clearly illustrated by the EM micrograph (Figure 9C) and also implied by the
fact that Connexin 29, a gap junction protein, co-localizes with MAG within these
compartments (Figure 9B). Alternatively, one could imagine that gangliosides may be ligands for
MAG between paranodal loops and in Schmidt-Lanterman incisures but this has not been
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demonstrated yet. Within the uncompacted myelin compartments the intracellular domain of
MAG can interact with particular components from the cytoskeleton such as tubulin the core
component of the microtubular cytoskeleton (Figure 9B; (Kursula et al., 2001).
The disc or ring-like MAG positive structures observed in the myelin sheaths resemble the ones
of E-cadherin and MUPP, two proteins known to be expressed in ring-like structures (Fannon et
al., 1995; Poliak et al., 2002). These radial- and disk-like MAG structures could either represent
funnel-shaped Schmidt-Lanterman incisures having MAG only expressed in a subdomain or they
could represent incisures-related structures such as zigzag-orientated Schmidt-Lanterman
incisures. The latter have been observed in our EM study and have been described by Robertson
and collaborators as well (Robertson, 1958). The expression of MAG in these ring-like structures
that include the outermost myelin lamellae, together with MAG expressed in the outer
mesaxon, may represent the link of the myelin sheath with the overlying basal lamina, since
MAG has been reported to interact with collagen, tenascin-R and fibronectin that are expressed
in the Schwann cell basal lamina (for review see (Quarles, 2002).
L-MAG CNS expression pattern diverges from the pattern of S-MAG and MBP
In adult brain sections we found a differential expression pattern of L- and S-MAG in certain
forebrain regions. S-MAG was the predominant isoform in distinct fiber bundles of the
cingulum as well as in the dorsal fornix. The strong and comparable expression of S-MAG and
MBP in the major myelinated fiber tracts suggests that S-MAG is mainly involved in myelin
maintenance. L-MAG, in contrast, stays persistently upregulated in particular myelinated fibers
of the corpus callosum, in the striatum as well as in the perforant pathway. The definite identity
of these L-MAG positive fibers could not be elucidated yet and needs further investigations.
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Figure 9 Schematic drawing of a typical peripheral myelin sheath with the described S-MAG-
GFP localization in different myelin compartments. (A) S-MAG is localized in the periaxonal
plasma membrane possibly interacting with its axonal binding partners GD1a and GT1b, NgR1/2
and p75. S-MAG is also present in non-compact compartments such as Schmidt-Lanterman
incisures and paranodal loops where it could interact with itself or other partners on the
opposite membrane. (B) Note that the opposing membranes in Schmidt-Lanterman incisures
and paranodal loops remain in close contact in a comparable manner as for the intraperiode line
in the compact myelin sheath indicated by the EM micrograph in C. Therefore, we suggest that
the extracellular domain of MAG with its five Ig-like domains requires to be bent due to this
spatial restriction. Zigzag shaped incisures might be a variant of the “classical” Schmidt
Lanterman incisures as described by Robertson et al. (1958). The significance of the different
ring-like structures around the axon and at the outside of the myelin sheath remains to be
defined. Abbreviations: mdl, major dense line; ip, intraperiode line; ic, intracellular compartment
of a Schmidt-Lanterman incisures.
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S-MAG is expressed in the mouse CNS paranodal loops
There have been controversial statements from earlier Immuno-EM studies about MAG
expression in CNS paranodes (Bartsch et al., 1989; Trapp et al., 1989). We found S-MAG-GFP
accumulated in the paranodal loops quite frequently, which is in agreement with the study
reported by Bartsch and colleagues (Bartsch et al., 1989). A possible functional role of MAG
could be the stabilization of the paranodal loops through its self-adhesive properties in a trans-
interaction manner (Poltorak et al., 1987; Almazan et al., 1992). This idea is supported by the
observation of loosened paranodal loops in the CNS of MAG knock out and MAG/CGT double
knockout mice (Marcus et al., 2002; Schaeren-Wiemers et al., 2004), and also in the MAL-
deficient mice that showed a strong reduction of MAG (Marcus et al., 2002; Schaeren-Wiemers
et al., 2004).
Conclusion
In summary, our data provide new insights in the subcellular distribution of the two MAG
isoforms, which is fundamental for the understanding of their specific functions in myelin
formation and maintenance. Our observations show that the S-MAG-GFP transgenic mouse is
an excellent animal model since it bright autofluorescence allows also the examination of S-
MAG expression and myelination per se in in vitro myelinating DRG cocultures (Figure 8C and D)
as well as in cerebellar slice cultures (data not shown). Further, it will enable us in the future to
examine the dynamic processes during the formation of Schmidt-Lanterman incisures or
paranodal structures by time-lapse studies. This mouse line can also be bred with other mouse
strains to study the functional role of MAG under particular pathophysiological conditions of the
myelin sheath.
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Early axonal pathology in a mouse model for CMT1A disease (Part II)
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The following section is based on the manuscript submitted in December 2006. The part
“Materials and Methods” was extended.
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1 Abstract
Neurofilaments are implicated in the determination of proper axonal diameter and thereby in
the establishment and maintenance of correct nerve conductivity. Mice overexpressing human
PMP22 (mouse line C22) have predominantly myelinated fibers with small calibers and a slowed
nerve conduction velocity reflecting the pathology of CMT1A disease. Here, we describe the
expression of the neurofilament heavy, medium and light chains in sciatic nerves of C22 mice. In
these mice, we found a marked increase of neurofilament heavy chain (NF-H) relative to the
medium and light chains in developing and adult sciatic nerves. In addition, the analysis of the
neurofilament phosphorylation state showed that in C22 mice the majority of NF-H was not
phosphorylated in contrast to wild type mice. In wild type animals, most of the phosphorylated
NF-H was detected in the stationary pool of neurofilaments representing filamentous subunits,
whereas the non-phosphorylated was mainly detected in the mobile pool consisting of
monomeric subunits. In C22 mice, however, we detected non-phosphorylated NF-H in both, the
stationary and mobile pool of neurofilaments. We suggest that high levels of non-
phosphorylated NF-H especially in the stationary pool of neurofilaments might exert a
destabilizing effect on the neurofilament network in C22 mice. As both, unbalanced
stoichiometries and decreased phosphorylation of neurofilaments are associated with reduced
axon calibers, we conclude that in CMT1A disease, they might be the underlying mechanisms
that inhibit radial growth and lead ultimately to axonal atrophy.
2 Introduction
Charcot-Marie-Tooth disease (CMT) is the most frequent hereditary peripheral neuropathy. The
CMT1A subtype affects about 75% of the patients (Skre, 1974). CMT1A is classified as
demyelinating disease and caused by duplication of the DNA region encoding the peripheral
myelin protein PMP22 or by a point-mutation within this gene (Roa et al., 1991; Patel et al.,
1992; Suter et al., 1992). The overexpression of PMP22 has been described to disturb Schwann
cell maturation and to cause metabolic perturbations (Magyar et al., 1996; Notterpek et al.,
1999; Niemann et al., 2000; Fortun et al., 2006). Studies have shown that CMT1A leads to
distal weakness, atrophy and sensory loss caused by length-dependent degeneration of motor
and sensory axons (Krajewski et al., 2000). Demyelination precedes the occurrence of clinical
symptoms that correlate with axonal degeneration (Bouche et al., 1983; Berciano et al., 1989;
Nicholson, 1991; Garcia et al., 1998). For CMT1A patients, therapeutic approaches reducing
PMP22 levels are discussed (Sereda et al., 2003; Passage et al., 2004).
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In peripheral demyelinating neuropathies, abnormal Schwann cells are thought to induce axonal
dysfunction. Evidence for this comes from transplantation experiments where allografts from
Trembler-mice (point-mutation in PMP22) were used as bridges to connect the proximal and
distal stumps of transected nerves from normal mice. Regenerating axons penetrating the
allograft showed reduced calibers, higher neurofilament density, and a low phosphorylation
state, alterations that were restored in the distal host-derived part of the nerve containing wild
type Schwann cells (de Waegh et al., 1992).
The precise mechanisms by which abnormal Schwann cells exert adverse effects on axons,
especially on neurofilaments, the major components of the axonal cytoskeleton, are not known.
Neurofilaments are important for the establishment and maintenance of axonal calibers. They
are polymers consisting of three intermediate filament proteins, NF-L, NF-M and NF-H (light,
medium and heavy chain). The NF subunits are composed of a conserved helical core region,
flanked by the head (N-terminus) and hypervariable tail (C-terminus) domains. The tail domains
of NF-M and especially NF-H can be extensively phosphorylated. Neurofilament numbers,
subunit stoichiometries and the phosphorylation of their tail domains have been suggested to
specify axonal diameter (Ohara et al., 1993; Xu et al., 1996). One hypothesis is that myelination
induces neurofilament tail phosphorylation leading to increased neurofilament spacing which is
associated with an increase of axonal diameters (Starr et al., 1996). MAG, the myelin-
associated-glycoprotein localized in the periaxonal membranes has been suggested to mediate
phosphorylation of neurofilaments as in MAG knock out mice neurofilament spacing and
phosphorylation state are decreased. (Sternberger et al., 1979; Yin et al., 1998). MAG has been
suggested to regulate Cdk5 and ERK1/2 kinases that phosphorylate NF tail domains (Dashiell et
al., 2002).
In this work, we investigated the developmental effect of dysmyelination on the axon in CMT1A
animal model. For this we used the mouse line C22 that shows a dysmyelinating phenotype and
closely reflects the pathology of human CMT1A disease (Huxley et al., 1996; Robaglia-Schlupp
et al., 2002). We followed the establishment of the axonal cytoskeleton with focus on the
neurofilament subunit composition and phosphorylation in C22 mice. We found early
pathological alterations of the neurofilament subunit composition and phosphorylation and
suggest that they may be responsible for reduced radial growth leading to the observed axonal
atrophy in C22 mice. We also analyzed whether the expression of MAG, a potential regulator of
axonal growth, may be altered in C22 mice and CMT1A patients.
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3 Material and Methods (Part II)
3.1 Mouse model for CMT1A
The PMP22 overexpressing mice (line C22, kindly provided by Clare Huxley) carry 7 copies of the
human PMP22 gene (YAC construct) resulting in a peripheral neuropathy closely reflecting the
CMT1A pathology observed in humans (Huxley et al., 1996).
3.2 Electron microscopy
Sciatic nerves were fixed in situ with Karnovsky solution (3% paraformaldehyde, 3%
glutaraldehyde, 0.1 M Cacodylate buffer) for 5 min (detailed protocol in Material and Methods
Part I). For further fixation, tissue was incubated in Karnovsky solution for 3 h and stored in 2%
glutaraldehyde. Postfixation with osmium tetroxide, dehydration and EPON embedding were
performed as described before (Bartsch et al., 1995). Ultrathin sections of 70-80 nm were
contrasted by Uranyl-acetate and Pb-Citrate. Sections were imaged with transmission electron
microscope (Morgani 268 D; Philips) with a magnification of 2200x (Figure 1) or 4400x for the
analysis of different nerve compartments.
Determination of the proportion of axonal compartment in sciatic nerves
Sampling strategy: Sciatic nerve cross sections on 150 mesh grids were used for analysis. 25
pictures were taken (on 5 random meshs 5 pictures each with 4400x magnification) and
overlaid with 2 µm square grids. The compartments on 80 points of intersection were
determined (myelin, axonal, extracellular compartments) for analysis.
Axonal diameters and myelin sheath thickness were calculated from the areas of myelinated
fibers and axons (C22: n=296; wild type: n=195).
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3.3 Western blotting
Tissue preparation for Western blot analysis
The quantification of myelin proteins was done with sciatic nerve myelin membrane
preparations purified as described before. For the myelin preparation sciatic nerves of 8 animals
were pooled (detailed protocol in Material and Methods Part I) (Schaeren-Wiemers et al., 2004).
For neurofilament Western blot analysis, one sciatic nerve pair was homogenized in 500µl 0.1M
Tris-buffer containing the protease inhibitors PMSF (1 mM), Pepstatin A (1 µg/ml), Leupeptin (2
µg/ml), Aprotinin (0.5 µg/ml) and phosphatase inhibitors NaF, NaN3, pNPP, NaPPi, β-
Glycerophosphate (10 mM each). 5 µg protein were loaded for analysis. For the
subfractionation and Triton-extraction, one sciatic nerve pair was homogenized in 1200 µl ice-
cold 50 mM Tris (pH 7.5) buffer containing 1% Triton X-100, 25 mM KCl, 2 mM MgCl2, 5 mM
EGTA, protease and phosphatase inhibitors as described above. Homogenates were centrifuged
at 43000 g for 90 min, the supernatant was collected and the pellet resuspended in 1200 µl
buffer. 10 µl of supernatant and resuspended pellets were analyzed.
For Cdk5 Western blot analysis, one sciatic nerve pair was homogenized in 300 µl RIPA buffer
containing 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 0.1% SDS, 50 mM NaF, protease
inhibitors as described above, 20 mM Tris-HCl (pH 7.4), boiled at 95° C for 10 min and
centrifuged for 30 min at 10000 g. Supernatants were collected, and 25 µg proteins were
analyzed.
Myelin protein quantification
Myelin protein concentrations were determined by Bradford assay (detailed protocol in Material
and Methods Part I). Protein concentrations of sciatic nerve homogenates for neurofilament and
Cdk5 western blots were measured by BCA assay according to manufacturer protocol (Micro
BCA Protein Assay Kit, Pierce). A BSA standard dilution series was prepared (5, 25, 50, 125 and
250 µg/ml). Protein homogenates were diluted 1:10 or 1:100. 20 µl of the diluted samples and
200 µl BCA reagent were mixed and incubated at 37 °C for 1 h. The absorbance at 562 nm was
measured and protein concentrations calculated.
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SDS-PAGE/ Western blotting
Western blotting of myelin proteins was performed as described before (detailed protocol in
Material and Methods Part I; Schaeren-Wiemers et al., 2004). Neurofilaments analysis was
performed on 3-8% NuPAGE Novex Tris-acetate gels (Invitrogen) under non-reducing
conditions. Samples were mixed with LDS sample buffer (106 mM Tris HCl, 141 mM Tris base,
2% lithium dodecyl sulfate, 10% glycerol, 0.51 mM EDTA, 0.22 mM Comassie G250, 0.175
mM phenol red, pH8.5) heated for 10 min at 70 °C and loaded on the gel. Cdk5 analysis was
done on standard 10% SDS-PAGE.
Primary Antibodies: anti-neurofilament heavy chain (specific for phosphorylation independent
epitope, monoclonal, clone N52, Sigma), anti-NF-M (polyclonal, Biomol Int.), anti-NF-L
(monoclonal, clone DA2, Abcam), anti-MAG (polyclonal, kindly provided by Dr. Anthony Heape,
Oulu, Finland), anti-MBP (monoclonal, MAB386, Chemicon), anti-P0 (monoclonal, kindly
provided by Dr. Archelos, Karl-Franzens University, Graz, Austria), anti-PMP22 (polyclonal, kindly
provided by Dr. U. Suter, ETH-Hönggerberg, Zürich, Switzerland), anti-Cdk5 (Santa Cruz
Biotechnology).
Secondary Antibodies: goat anti-mouse Alexa Fluor 680 and goat anti-rabbit IRDye 800 (LI-COR
Biosciences GmbH), goat anti-rat IRDye (Rockland).
3.4 Immunohistochemistry
Human tissue (suralis nerves) was obtained either from biopsies or autopsies (kindly provided by
Prof. Dr. Taroni (Milan)), mouse tissue (sciatic nerves) from the CMT1A mouse line (C22).
Consecutive cryostat sections were mounted on gelatin-chromalaun-coated slides. Fixation,
delipidation and staining were performed as described before (detailed protocol in Material and
Methods Part I; Gabriel et al., 1996). The blocking buffer for mouse tissues was PBS containing
0.1% fish skin gelatin, 2.5% normal goat serum, 0.05% Saponin. Detection was performed
with secondary horseradish peroxidase coupled antibodies (mouse or rabbit, SIGMA). Cell nuclei
were counterstained with Mayer’s Haemalaun (Merck). For immunofluorescence analysis, slides
were incubated with secondary fluorochrome antibodies.
Primary Antibodies: anti-human MAG (specific for extracellular epitope D3A2G5, monoclonal,
(Burger et al., 1990), anti-human P0 (monoclonal, D4IE4, (Miller et al., 1984), anti-MAG
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(monoclonal, clone 513, Boehringer Mannheim), anti-MAL (Schaeren-Wiemers et al., 2004),
anti-PMP22 (kindly provided by Prof. Dr. U. Suter, ETH-Hönggerberg, Zürich, Switzerland).
Secondary antibodies: Goat anti-mouse and goat anti-rabbit peroxidase antibodies (Jackson
ImmunoResearch), goat anti-mouse Alexa 555 and goat anti-mouse Alexa 488 (Molecular
Probes).
Quantitative image analysis
Mouse sciatic nerve cross sections: For the quantitative analysis of MAG expression, we
performed a double staining for MAG and PMP22 or MAL on sciatic nerve cross sections. For
quantification we measured the areas of MAG and PMP22 or MAL, positively stained surfaces
within single myelinated fibers. We defined two circular areas of different size to analyze large
and small caliber fibers separately. We calculated the ratios MAG/PMP22 and MAG/MAL for 50
large and 50 small myelinated fibers in wild type mice and 50 small myelinated fibers in C22
mice. For comparison we used the mean values. For quantitative image analysis “Analysis” (SIS,
Münster, Germany) software was used.
Human suralis nerve biopsies/autopsies: Quantifications of MAG expression were performed
with biopsies from 3 CMT1A patients and 3 control autopsies. 10 test fields (11011 µm2 each)
per section were analyzed using a Leica Dialux 20 microscope (Leitz, Wetzlar, Germany) and a
40x objective. On consecutive sections, fibers positive for P0 and MAG were counted on test
fields. MAG expression was indicated as the percentages of MAG positively stained fibers
compared to P0 positively stained nerve fibers. On the same sections, areas stained for MAG
and P0 were measured and the ratios of MAG/P0 were calculated. Cameras: JVC KY-F55; F-
View, Soft Imaging System.
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4 Results
4.1 Morphological characteristics of the myelinated fibers of sciatic nerves in an
animal model for CMT1A disease
There are many different animal models for CMT1A disease (Robertson et al., 2002). One
animal model, which closely resembles the human pathology of CMT1A disease, is the C22
transgenic mouse overexpressing human PMP22 (Huxley et al., 1996). A morphological
characterization of sciatic nerves during development revealed that the onset of myelination is
delayed in C22 mice and that only a small percentage of fibers is correctly myelinated (Robaglia-
Schlupp et al., 2002). For illustration of these findings, we show in Figure 1A developmental
stages of C22 mice (postnatal day 10 and 20). At P10, the number of myelinated fibers is clearly
reduced and myelin sheathes are thinner in C22 compared to wild type mice. This reduction in
number of myelinated fibers and myelin sheath thickness is also seen at P20. In addition, we
analyzed the morphology of the sciatic nerves at P60 (Figure 1A, P60). Until P60, myelinated
fibers enlarge their calibers in wild type mice, which is not observed to the same extent in C22
mice. At P60, small caliber myelinated axons still predominate in C22 mice and show a
considerable heterogeneity in myelin sheath thickness (Figure 1A and 1B). To closer assess the
observed heterogeneity of myelinated fibers, we analyzed a representative number of
myelinated fibers in C22 mice and defined different subpopulations of myelinated fibers
according to their g-ratios. For this analysis we first defined the range of g-ratios in wild type
mice. The g-ratio of 95% of myelinated fibers was between 0.5 and 0.77 in wild type animals;
therefore, we considered myelinated fibers with g-ratios above 0.77 as hypomyelinated and
those with g-ratios below 0.5 as hypermyelinated. In C22 mice, about 45% of the fibers are
normally myelinated (Fig 1B: asterisks). About 20% of the axons are surrounded by Schwann
cells, 1:1, but lack myelin (Figure 1B, dots; 1C, open circles). Approximately 30% of the fibers
are hypomyelinated (Figure 1B, arrowheads; some fibers have only 2-3 layers of myelin layers).
Axons lacking myelin and hypomyelinated axons constitute about 65% of the axonal volume in
sciatic nerves of C22 mice. In C22 mice, a minority of about 5% of fibers is hypermyelinated
(Figure 1B, arrow). The relative abundance of the different fiber populations is illustrated in
Figure 1C.
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Figure 1 Myelination and axonal growth during development and in adult C22 and wild type
mice. (A) Electron micrographs of sciatic nerves cross sections at postnatal day 10, 20 and 60.
Most characteristic for C22 mice at P10 and P20 is the reduced number of myelinated fibers,
the reduced myelin sheath thickness and the decreased fiber diameters. At P60, small caliber
fibers still predominate and the myelin sheath thickness varies considerably. (B) The variability of
myelin sheathes in C22 mice at P60: “normal” myelinated axons (asterisks), hypomyelinated
axons (arrowheads), hypermyelinated axon (arrow) and axons surrounded by Schwann cells 1:1
without myelin (dots). (C) Scatter plot of myelin sheath thickness versus axon diameter: wild
type axons (open squares) and C22 axons (myelinated axons: filled circles; axons lacking myelin:
open circles). (D) Distribution of axonal diameters in C22 and wild type mice (median). Note,
that large caliber axons with diameters above 4000 nm are almost absent in C22 mice at P60.
Scale bars: (A) 10 µm, (B) 2.5 µm.
Axonal changes in CMT1A disease
74
Apart from the wide heterogeneity of myelinated fibers in C22 mice, the almost complete
absence of large caliber myelinated fibers is a particular feature of C22 mice. Figure 1D
illustrates the distribution of the axonal diameters in C22 mice and shows that myelinated fibers
with diameters above 4000nm are almost absent. In this work, our main interests are the
molecular alterations that could contribute to the overall reduced axon diameters of myelinated
fibers in C22 mice.
4.2 Alterations in the neurofilament subunit composition and phosphorylation in
CMT1A mice
It is generally thought that axon calibers are determined by the content and properties of
neurofilaments. Therefore, we investigated whether the axonal cytoskeleton is altered in C22
mice with special focus on neurofilament expression and phosphorylation.
We analyzed the content of the heavy, medium and light chains as well as phosphorylation
state of neurofilaments in sciatic nerve homogenates of adult C22 mice (Figure 2A). The
electrophoretic mobility of heavy chain depends on the phosphorylation state of the tail
domain. Phosphorylated NF-H (NF-HP) runs at 200 kD, whereas the non-phosphorylated NF-H
(NF-H) runs at 160-170 kD. In wild type mice, the NF heavy chain is predominantly
phosphorylated, whereas in C22 mice the majority is non-phosphorylated. In addition, the levels
of non-phosphorylated NF-H relative to NF-M (140-160 kD) and NF-L (70 kD) are strongly
increased compared to the wild type, which results in an altered neurofilament subunit
composition. Levels of NF-M and NF-L are not significantly altered in C22 mice.
It has been hypothesized that the distances between neurofilaments are determined by the
phosphorylation of the tail domains (Yin et al., 1998). Tail phosphorylation was proposed to
increase neurofilament nearest neighbor distances (NND) and thereby to enlarge axonal
diameters. To see whether increased levels of non-phosphorylated NF-H correlate with
decreased NNDs and reduced axonal diameters, we examined NND in C22 mice qualitatively.
We observed that the hypomyelinated axons of C22 mice show an irregular neurofilament
distribution with varying NNDs (Figure 2C and D: C22, arrows) compared to axons with
appropriate myelin sheath thickness (Figure 2B: wild type or 2D: C22, arrowheads). However, a
correlation of NNDs with axon diameters was not evident (data not shown).
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Figure 2 Western blot analysis of the neurofilament subunit composition and phosphorylation
in 5 month-old C22 and wild type mice in sciatic nerve homogenates. (A) The Western blot
shows phosphorylated NF-H (200 kD), non-phosphorylated NF-H (170 kD), NF-M (160 kD) and
NF-L (70 kD) in wild type and C22 mice. Note the predominance of phosphorylated NF-H in wild
type mice in contrast to C22 mice with high proportions of non-phosphorylated NF-H. NF-M
and NF-L levels correlate in C22 and wild type mice. (B) Neurofilament distribution in a
myelinated wild type axon at P60: In wild type axons, neurofilaments are regularly distributed
(arrowhead). (C, D) Neurofilament distribution in C22 mice at P60: In hypomyelinated axons
and axons lacking myelin neurofilaments are irregularly distributed (C and D, arrows). Note, that
axons with appropriate myelin sheath thickness show a regular neurofilament distribution in
C22 mice (arrowhead). Scale bar: 0.5 µm.
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4.3 Equilibrium of stationary and mobile neurofilaments in CMT1A mice
Neurofilaments are either part of the stationary or mobile neurofilament pool. The cytoskeletal
polymers are stationary and in a dynamic equilibrium with transported non-filamentous
(monomers or oligomers) subunit proteins. The distribution of neurofilament subunits in the
mobile and stationary pool can be determined by Triton-extraction of nervous tissue followed by
differential fractionation (Shea et al., 1990; Shea et al., 1997). Triton insoluble neurofilaments in
the pellet fractions correspond to the stationary neurofilament pool, whereas Triton-soluble
neurofilaments in the supernatants correspond to the mobile neurofilament pool. To clarify
whether the non-phosphorylated NF-H, which is substantially increased in C22 mice, is part of
the stationary polymers or the mobile pool, we determined the contents of neurofilament
subunits in the Triton-insoluble pellets (P) and Triton-soluble supernatants (S) at P10, P20 and
P60 (Figure 3A: wild type, 3B: C22).
In wild type animals, one can clearly distinguish the neurofilament composition of the pellet
fraction and supernatant fraction at P10. Both fractions differ in their subunit compositions. All
subunits (NF-H, NF-M and NF-L) are represented in the pellet, whereas only the non-
phosphorylated form of the heavy chain is detectable in the supernatant. At P20, the proportion
of phosphorylated NF-H is especially increased in the pellet, while the non-phosphorylated is the
predominant form in the supernatant resulting in a reciprocal distribution of NF-HP and NF-H in
these fractions. Between P20 and P60, the subunit composition and distribution does not
change anymore. Therefore, it seems that maturation of neurofilament subunit composition and
distribution is primarily marked by an increase of the phosphorylated NF-H in the stationary
neurofilament pool.
In C22 mice at P10, all subunits are only detectable at low levels in the pellet fraction, in
contrast to non-phosphorylated NF-H, which is abundant in the supernatant fraction. At P20, all
NF subunits are increased in the pellet; however, the increase of phosphorylated NF-H relative to
the other subunits is only moderate compared to the wild type at that time point. In C22 mice,
the characteristic increase of NF-HP as observed during maturation in wild type mice does not
occur, but levels of non-phosphorylated NF-H are further increased. In summary, we see that in
C22 mice, neurofilaments never reach a mature subunit composition and distribution as they
maintain high levels of non-phosphorylated NF-H in the stationary as well as in the mobile pool.
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Figure 3 Western blot analysis of neurofilaments in Triton X–insoluble (P) and soluble (S) sciatic
nerve fractions at P10, P20 and P60. (A) In wild type mice there is an increase of phosphorylated
NF-H in the pellet during development. Phosphorylated and non-phosphorylated NF-H are
reciprocally distributed between both fractions, phosphorylated NF-H is almost completely
incorporated into the pellet whereas non-phosphorylated NF-H is in the supernatant. NF-M and
NF-L are well detected in the pellet fractions already at P10 and levels further increase until P20
and P60. (B) In C22 mice, the increase of phosphorylated NF-H does not occur to the same
extent as in the wild type mice. Yet, non-phosphorylated NF-H accumulates in the pellet and
even more pronounced in the supernatants. The establishment of a stationary cytoskeleton is
delayed; not until P20, subunits can readily be detected in the pellet fraction.
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Figure 4 MAG expression under pathological conditions in murine and human CMT1A tissue.
(A) Double staining for MAG and PMP22 on cross sections from sciatic nerves of adult wild type
and C22 mice. In wild type mice, MAG is predominantly expressed in small caliber myelinated
fibers. In C22 mice, MAG expression appears stronger than in wild type mice. (B) Western blot
analysis of myelin membranes from sciatic nerves of adult wild type and C22 mice. The MAG
signal is stronger in C22 mice than wild type mice relative to the signals of the compact myelin
proteins MBP and P0. (C) Transversal sections from sural nerves of control autopsy and CMT1A
biopsies stained for MAG and P0. In CMT1A patients, the number of myelinated P0 positive
fibers is reduced. However, the number of MAG positive stained fibers relative to P0 positive
nerve fibers is higher in the CMT1A patients than in the control autopsy. Scale bar: (A) 50 µm,
(C) 20 µm.
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Table 1 MAG expression in C22 mice (sciatic nerves)
Fiber size ratios MAG/PMP22 ratios MAG/MAL
wt small
large
0.14
0.01
0.19
0.016
C22 small 0.31 0.409
Table 1: Quantitative analysis of MAG signals in myelinated fibers from wild type and C22
mice. For this analysis we performed a double staining for MAG and PMP22 or MAL on sciatic
nerve cross sections. For quantification we measured the areas of MAG and PMP22 or MAL
stained surfaces within single myelinated fibers. We calculated the ratios MAG/PMP22 and
MAG/MAL for 50 large and 50 small myelinated fibers in wild type mice and 50 small
myelinated fibers in C22 mice. Indicated on the table are the mean values. Note, that small
caliber myelinated fibers in wild type mice express more MAG than large ones. In C22 small
caliber myelinated fibers, MAG expression is higher than in the small fibers of wild type animals.
Table 2 MAG expression in CMT1A biopsies and control autopsies (suralis
nerves)
% MAG positive
myelinated fibers
ratios MAG/P0
CMT1A (mi5)
CMT1A (mi6)
CMT1A (mi7)
92%
88%
87%
0.1109
0.2124
0.6105
Control autopsy (S)
Control autopsy (U)
Control autopsy (X)
50%
79%
64%
0.0774
0.0454
0.0212
Table 2: Quantitative analysis of MAG expression in CMT1A patients and control autopsies.
Suralis nerve cross sections were stained for MAG and P0. Numbers of positively stained fibers
were counted and ratios of the numbers MAG/P0 calculated. In addition, areas positive for
MAG and P0 were measured and ratios of the areas MAG/P0 calculated. Both analysis indicate
an upregulation of MAG in CMT1A patients.
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4.5 Cdk5 kinase levels in sciatic nerves of CMT1A mice
There are several kinases involved in neurofilament phosphorylation, but Cdk5 is so far the only
one that has been described to induce the electrophoretic shift of NF-H by phosphorylation of
KSP sites of the tail domain (Guidato et al., 1996; Pant et al., 1997; Veeranna et al., 1998; Bajaj
et al., 1999; Shea et al., 2004). Cdk5 kinase was shown to be regulated by MAG and other
signaling pathways originating from integrin and growth factor receptors (Li et al., 2000;
Dashiell et al., 2002). To test whether altered Cdk5 levels are implicated in the pathogenesis of
CMT1A, we quantified Cdk5 in sciatic nerve tissue of C22 mice by Western blot analysis loading
equal amounts of proteins. At P10, Cdk5 protein expression was reduced in C22 probably
indicating delayed myelination. However, at P20 and P60, expression levels were comparable to
wild type ones (Figure 5).
For correct interpretation of Cdk5 levels it was necessary to consider the morphological
alterations of C22 mice (Figure 1). Therefore, we correlated Cdk5 expression levels to the
proportion of axonal area fraction of sciatic nerve cross sections. As the axonal area fraction was
only decreased from 31% to 25% (P60), we conclude that at P20 and P60 Cdk5 levels were
indeed comparable in C22 and wild type mice.
Figure 5 Western blot analysis of Cdk5 in sciatic nerve homogenates from wild type and C22
mice. At P10, levels of Cdk5 were reduced in C22 mice. At P20 and P60, Cdk5 levels were
comparable in C22 and wild type mice.
Axonal changes in CMT1A disease
82
5 Discussion
In this work, we addressed the question of how dysfunctional Schwann cells influence the
development and maturation of axons. For this study, we used PMP22 overexpressing mice as
an animal model for the CMT1A disease. As previously described, there is a predominance of
small caliber axons in PMP22 overexpressing mice (Robaglia-Schlupp et al., 2002). Since axon
calibers are mainly determined by the content of neurofilaments, we investigated whether
overexpression of PMP22 influences the neurofilament system. We studied the subunit
composition and phosphorylation state of neurofilaments during development and in adult C22
and wild type mice.
We analyzed the neurofilament subunit composition as well as the phosphorylation state and
distinguished between the stationary (Triton insoluble) and mobile (Triton soluble) pool of
neurofilaments. The most prominent pathological alteration in C22 mice is the absence of a
mature neurofilament subunit composition and phosphorylation. C22 mice maintain high levels
of non-phosphorylated NF-H in their stationary cytoskeleton and mobile neurofilament pool
relative to NF-M and NF-L. As these alterations of the neurofilament system occur already during
myelination they are reflecting an early abnormal Schwann cell signaling. Recent studies have
shown that PMP22 overexpression is associated with a dysmyelinating process and does not just
result from demyelination (Robaglia-Schlupp et al., 2002).
The importance of the neurofilament subunit composition and phosphorylation in the
regulation of axonal calibers has been well studied. Overexpression of individual neurofilament
subunits inhibits radial growth, whereas overexpression of the light chain with either the
medium or the heavy chains promotes radial growth (Xu et al., 1996). The absence of the light,
medium or heavy chains result in the reduction of axon calibers (Elder et al., 1998a; Elder et al.,
1998b). All these studies stress the importance of correct neurofilament subunit stoichiometry
for axonal growth. In C22 mice, the relative increase in NF-H levels is significant and this shifts
the neurofilament subunit composition.
How altered subunit compositions impair radial growth is not known, however, studies have
shown that the relative content of the heavy and medium chains has an impact on axonal
transport rates. Overexpression of the neurofilament heavy chain results in selective reduction in
the amount and rate of transport of neurofilament subunits which probably hampers the
establishment and maintenance of the neurofilament network (Marszalek et al., 1996). The
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neurofilament transport is mediated by the anterograde-specific motor protein kinesin, which
associates with non-phosphorylated neurofilaments. Phosphorylation of neurofilaments
promotes the dissociation from kinesin and the integration into the reticulated neurofilament
network (Jung and Shea, 1999; Yabe et al., 2000; Jung et al., 2005). Therefore, in C22 mice,
the excess of non-phosphorylated NF-H in the mobile pool of neurofilaments could interfere
with the kinesin dependent transport, so that the neurofilament transport itself but also vesicle
transport could be impaired.
Phosphorylation does not only regulate neurofilament transport but also the stability of the
neurofilament network. In vitro studies have clearly demonstrated that dephosphorylation of
neurofilaments results in the loss of their capacity to interconnect into a reticulated network
(Eyer and Leterrier, 1988). Therefore, high levels of non-phosphorylated NF-H especially in
stationary pool of neurofilaments might exert a destabilizing effect on the neurofilament
network in CMT1A disease. We found that hypomyelinated axons generally showed an irregular
neurofilament distribution compared to axons with a normal myelin sheath in C22 mice. The
irregular neurofilament distribution could reflect that the neurofilament network is not properly
established and destabilized in those axons. Considering the fact that hypomyelinated axons
constitute approximately 65% of the axonal volume in sciatic nerves, we speculate that those
fibers are primarily affected by the increase of non-phosphorylated NF-H seen on the Western
blots. It is possible that those hypomyelinated fibers correspond to the population from which
normally larger myelinated axons evolve.
The precise molecular mechanisms by which Schwann cells modulate the axonal properties
during myelination are not known. However, one molecular candidate involved in myelin-axon
interactions is MAG, the myelin associated glycoprotein localized at the Schwann cell-axon
interface of myelinated fibers (Sternberger et al., 1979). MAG has been suggested to upregulate
the activity of the Cdk5 and ERK1/2 kinase system, which is responsible for the phosphorylation
of neurofilament tails (Dashiell et al., 2002). Although we found in C22 mice increased
proportions of non-phosphorylated NF-H, MAG was upregulated in myelinated fibers in CMT1A
patients and mice. This upregulation of MAG detected in myelin membrane preparations may
reflect to some extent a general hypomyelination in C22 mice, but could also indicate a
compensatory mechanism to induce neurofilament phosphorylation, which may fail due to
disrupted downstream signaling. The significance of elevated MAG levels for axons in CMT1A
disease remains difficult to assess as many MAG receptors are suggested and downstream
signaling cascades are complex and not well defined (Franzen et al., 2001; Vinson et al., 2001b;
Venkatesh et al., 2005).
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We also directly analyzed the expression of Cdk5, which is the most important kinase for
neurofilament tail phosphorylation and has been implicated in the pathomechanisms of
neurodegenerative diseases such as ALS and Alzheimer’s disease (Nguyen et al., 2001; Noble et
al., 2003). Strikingly, Cdk5 expression levels were comparable in C22 and wild type mice. The
activity of Cdk5 could also be regulated by its activator p35 (Sun et al., 1996). Therefore we
performed Western blot analysis for p35, but we were not able to detect p35 in sciatic nerve
preparations of C22 mice as well as wild type (data not shown). To directly investigate whether
reduction of Cdk5 activity is responsible for reduced neurofilament phosphorylation in C22
mice, Cdk5 activity could be elevated in C22 mice by crossbreeding them with mice
overexpressing Cdk5 activator p35 or p25 (Ahlijanian et al., 2000).
How PMP22 overexpressing Schwann cells induce alterations in neurofilament subunit
composition and phosphorylation in CMT1A disease remains unclear. The fact that MAG is
overexpressed in periaxonal membranes in C22 mice and CMT1A patients suggests that
dysregulations of the neurofilament systems observed in PMP22 overexpressing mice and in
MAG knock out mice result from different pathways. It is likely that there are mediators other
than MAG involved in Schwann cell-axon communication and that different transduction
processes contribute to the regulation of neurofilament subunit composition and
phosphorylation.
In summary, we describe a primary effect of abnormal Schwann cells on the determination of
the axon caliber in CMT1A disease. We conclude that the signaling between the myelinating
cells and the axon is already impaired at the onset of myelination in CMT1A disease leading
ultimately to axonal atrophy.
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